Skip to main content
SCHEDULE
Full Schedule
Browse By Date
Saturday, October 20, 2018
Sunday, October 21, 2018
Monday, October 22, 2018
Tuesday, October 23, 2018
Wednesday, October 24, 2018
Browse By Speakers
Browse by Track
Browse by Session Type
Keyword Search
MEETING SURVEY
EXHIBITS
Featured Exhibitors
Search by Name
Search by Category
Floorplan
PRODUCT
SHOWCASE
Browse by New Product
Browse by Product Name
Browse by Company Name
Browse by Product/Service Category
EXHIBITOR EVENTS
ABSTRACTS
Browse by Track
Browse by Session Type
Browse by Presenter
MEETING INFO
ASTRO On-site Resources
Food Service
On-site Services
Registration Hours
Shuttle Service, Transportation and Parking
Speaker Assistance
Maps
ASRT Meeting
SROA Meeting
VIRTUAL MEETING
Login
Toggle navigation
Home
MySchedule
SCHEDULE
Full Schedule
Browse By Date
Saturday, October 20, 2018
Sunday, October 21, 2018
Monday, October 22, 2018
Tuesday, October 23, 2018
Wednesday, October 24, 2018
Browse By Speakers
Browse by Track
Browse by Session Type
Keyword Search
MEETING SURVEY
EXHIBITS
Featured Exhibitors
Search by Name
Search by Category
Floorplan
PRODUCT
SHOWCASE
Browse by New Product
Browse by Product Name
Browse by Company Name
Browse by Product/Service Category
EXHIBITOR EVENTS
ABSTRACTS
Browse by Track
Browse by Session Type
Browse by Presenter
MEETING INFO
ASTRO On-site Resources
Food Service
On-site Services
Registration Hours
Shuttle Service, Transportation and Parking
Speaker Assistance
Maps
ASRT Meeting
SROA Meeting
VIRTUAL MEETING
Browse by Track
Browse by Track
Type here to filter the list
ARRO
Saturday, Oct 20
10:00 am
Opening Remarks by the ARRO Executive Committee
Location: Hemisfair Ballroom 3
Jenna Kahn, MD – Virginia Commonwealth University Health System
Saturday, Oct 20
10:00 am
ARRO Annual Seminar - (INTERACTIVE) ARRO Annual Seminar
Location: Hemisfair Ballroom 3
Saturday, Oct 20
10:10 am
Opening Remarks by the ARRO Executive Committee
Location: Hemisfair Ballroom 3
Ashley Albert, MD
Saturday, Oct 20
10:16 am
Global Health Scholar Presentation_1
Location: Hemisfair Ballroom 3
Serguei Castaneda, MD
Saturday, Oct 20
10:22 am
Global Health Scholar Presentation_2
Location: Hemisfair Ballroom 3
Adam Olson, MD, MS
Saturday, Oct 20
10:28 am
Global Health Scholar Presentation_3
Location: Hemisfair Ballroom 3
Sherry Zhao, MD
Saturday, Oct 20
10:34 am
Radiating Hope: Life Outside of Medicine and Adventures in Other Countries
Location: Hemisfair Ballroom 3
Larry Daugherty, MD
Saturday, Oct 20
10:54 am
ROI Presentation-Research for the Future of Our Profession
Location: Hemisfair Ballroom 3
Robert Miller, MD, MBA, FASTRO
Saturday, Oct 20
11:04 am
Financial and Contracts
Location: Hemisfair Ballroom 3
Nikhil Thaker, MD, BS
Saturday, Oct 20
12:04 pm
Breakout Session For Scientist Luncheon, Women, in Radiation Oncology, Finance/contracts small groups
Location: Hemisfair Ballroom 3
Terry Wall, MD, JD, FASTRO – TRI, PA
Saturday, Oct 20
1:04 pm
Radiation Oncology Career Journeys: Vocation, Inspiration, and Rewriting Your C.V
Location: Hemisfair Ballroom 3
Tracy Balboni, MD, MPH – Brigham and Women's Hospital
Saturday, Oct 20
2:19 pm
Applying for Jobs: A Panel Discussion - Moderator
Location: Hemisfair Ballroom 3
Lisa Kachnic, MD, FASTRO – Vanderbilt University Medical Center
Saturday, Oct 20
2:20 pm
Applying For Jobs Panel? - Private Practice
Location: Hemisfair Ballroom 3
Leah Katz, MD
Saturday, Oct 20
2:31 pm
Applying For Jobs Panel - Academic
Location: Hemisfair Ballroom 3
Lindsay Burt, MD
Saturday, Oct 20
2:42 pm
Applying For Jobs Panel - Private Practice
Location: Hemisfair Ballroom 3
Guy Jones, MD
Saturday, Oct 20
2:53 pm
Applying For Jobs Panel - Physician Scientist
Location: Hemisfair Ballroom 3
Aparna Kesarwala, MD, PhD – National Cancer Institute
Saturday, Oct 20
3:05 pm
Educational session: Innovative Radiation Oncology - eContour
Location: Hemisfair Ballroom 3
Erin Gillespie, MD
Saturday, Oct 20
3:35 pm
Educational session: Innovative Radiation Oncology - themednet.org
Location: Hemisfair Ballroom 3
Nadine Housri, MD
Saturday, Oct 20
4:05 pm
Practice Entry Survey Results
Location: Hemisfair Ballroom 3
Terry Wall, MD, JD, FASTRO – TRI, PA
Saturday, Oct 20
6:00 pm
ARRO Reception - ARRO Reception
Sunday, Oct 21
12:15 pm
Topic for 2018
Location: Room 302
Brian Kavanagh, MD, MPH, FASTRO
Sunday, Oct 21
12:15 pm
ARRO Annual Luncheon - ARRO Annual Luncheon
Location: Room 302
Sunday, Oct 21
4:45 pm
ARRO MTP - ARRO Meet the Professor Reception
Location: Room 302
Sunday, Oct 21
4:46 pm
Meet the Professor
Location: Room 302
Laura Dawson, MD, FASTRO – Princess Margaret Hospital
Sunday, Oct 21
4:47 pm
Meet the Professor
Location: Room 302
Nadine Housri, MD
Sunday, Oct 21
4:48 pm
Meet the Professor
Location: Room 302
Joachim Yahalom, MD, FASTRO – Memorial Sloan Kettering Cancer Center
Sunday, Oct 21
4:49 pm
Meet the Professor
Location: Room 302
Jonathan Knisely, MD, FASTRO – Weill Cornell Medical College
Sunday, Oct 21
4:50 pm
Meet the Professor
Location: Room 302
Charles Thomas, MD – Oregon Health and Science University
Sunday, Oct 21
4:51 pm
Meet the Professor
Location: Room 302
Alexander Louie, MD, PhD, MSc, FRCPC – Sunnybrook Health Sciences Centre - Canada
Sunday, Oct 21
4:52 pm
Meet the Professor
Location: Room 302
Colleen Lawton, MD, FASTRO – Medical College of Wisconsin
Sunday, Oct 21
4:53 pm
Meet the Professor
Location: Room 302
Allen Chen, MD – University of Kansas School of Medicine
Sunday, Oct 21
4:54 pm
Meet the Professor
Location: Room 302
Timothy Williams, MD, FASTRO
Sunday, Oct 21
4:55 pm
Meet the Professor
Location: Room 302
Yoshiya Yamada, MD, FRCPC – Memorial Sloan Kettering Cancer Center
Sunday, Oct 21
4:56 pm
Meet the Professor
Location: Room 302
Lawrence Marks, MD, FASTRO
Sunday, Oct 21
4:57 pm
Meet the Professor
Location: Room 302
Matthew Katz, MD, FASTRO
Sunday, Oct 21
4:58 pm
Meet the Professor
Location: Room 302
Terence Sio, MD, MS
Monday, Oct 22
12:15 pm
ARRO Poster Viewing - ARRO Poster Viewing With a Professor
Location: Innovation Hub, Exhibit Hall 3
Monday, Oct 22
12:15 pm
Biology Track
Location: Innovation Hub, Exhibit Hall 3
Brian Marples, PhD – University of Miami
Monday, Oct 22
12:15 pm
Breast Track
Location: Innovation Hub, Exhibit Hall 3
Suzanne Evans, MD – Yale University
Monday, Oct 22
12:15 pm
Central Nervous System Track
Location: Innovation Hub, Exhibit Hall 3
Stephanie Weiss, MD, FASTRO – Fox Chase Cancer Center
Monday, Oct 22
12:15 pm
Education & History in Radiation Oncology Track
Location: Innovation Hub, Exhibit Hall 3
Daniel Golden, MD, MHPE
Monday, Oct 22
12:15 pm
Gastrointestinal Track
Location: Innovation Hub, Exhibit Hall 3
Salma Jabbour, MD – Rutgers Cancer Institute of New Jersey
Monday, Oct 22
12:15 pm
Genitourinary Track
Location: Innovation Hub, Exhibit Hall 3
Bridget Koontz, MD
Monday, Oct 22
12:15 pm
Gynecological Track
Location: Innovation Hub, Exhibit Hall 3
David Gaffney, MD, PhD, FASTRO – University of Utah
Monday, Oct 22
12:15 pm
Head & Neck Track
Location: Innovation Hub, Exhibit Hall 3
Farzan Siddiqui, MD, PhD
Monday, Oct 22
12:15 pm
Lung Track
Location: Innovation Hub, Exhibit Hall 3
Gregory Videtic, MD, CM, FRCPC, FASTRO – Cleveland Clinic
Monday, Oct 22
12:15 pm
Lymphoma Track
Location: Innovation Hub, Exhibit Hall 3
Kenneth Roberts, MD
Monday, Oct 22
12:15 pm
Patient Reported Outcomes/QoL/Survivorship Track
Location: Innovation Hub, Exhibit Hall 3
Ronald Chen, MD, MPH – University of North Carolina
Monday, Oct 22
12:15 pm
Pediatrics Track
Location: Innovation Hub, Exhibit Hall 3
Stephanie Terezakis, MD – Johns Hopkins School of Medicine
Monday, Oct 22
12:15 pm
Sarcoma/Non-malignant
Location: Innovation Hub, Exhibit Hall 3
Yen-Lin Chen, MD – Massachusetts General Hospital
Breast Cancer
Sunday, Oct 21
1:15 pm
eContouring for Breast Cancer
Location: Room 303
Jennifer Bellon, MD, FASTRO – Dana-Farber Cancer Institute
Sunday, Oct 21
1:15 pm
eContouring for Breast Cancer
Location: Room 303
Stephanie Terezakis, MD – Johns Hopkins School of Medicine
Sunday, Oct 21
1:15 pm
eContouring for Breast Cancer
Location: Room 303
Karyn Goodman, MD, MS – University of Colorado Cancer Center
Sunday, Oct 21
1:15 pm
eContouring 05 - eContouring for Breast Cancer
Location: Room 303
Sunday, Oct 21
1:35 pm
eContouring for Breast Cancer
Location: Room 303
Jean Wright, MD – Sibley Memorial Hospital
Sunday, Oct 21
4:45 pm
Axillary surgery considerations in the era of neoadjuvant systemic therapy
Location: Room 214 A/B
Judy Boughey, MD
Sunday, Oct 21
4:45 pm
EDU 04 - (INTERACTIVE) Management of the Axilla and Neoadjuvant Systemic Therapy
Location: Room 214 A/B
Rachel Jimenez, MD
Sunday, Oct 21
5:10 pm
Radiation Considerations in the Era of Neoadjuvant Systemic Therapy
Location: Room 214 A/B
Julia White, MD, FASTRO
Sunday, Oct 21
5:35 pm
Lymphedema and other Quality-Of-Life Considerations after Neoadjuvant Systemic Therapy
Location: Room 214 A/B
Simona Shaitelman, MD, EdM
Sunday, Oct 21
6:00 pm
Audience Q&A
Location: Room 214 A/B
Rachel Jimenez, MD
Monday, Oct 22
10:45 am
83 - A Nomogram for Predicting Lymphedema Risk Following Axillary Surgery and Regional Nodal Irradiation Developed From the NCIC MA.20 Trial
Location: Room 214 C/D
Jeffrey Gross, MD, MS – Northwestern University
Monday, Oct 22
10:45 am
SS 12 - Breast 1 - Toxicity
Location: Room 214 C/D
Dean Shumway, MD – University of Michigan; Matthew Poppe, MD
Monday, Oct 22
10:55 am
84 - NRG Oncology/RTOG 1014: Patient Reported Outcomes (PRO) and Cosmesis From a Phase II Study of Repeat Breast Preserving Surgery and 3D Conformal (3D-CRT) Partial Breast Re-Irradiation (PBrI) for In-Breast Recurrence.
Location: Room 214 C/D
Douglas Arthur, MD, FASTRO – Virginia Commonwealth University
Monday, Oct 22
11:05 am
85 - Reconstruction Failure Rates in Breast Cancer Patients With Two-Stage Expander/Implant Reconstruction Receiving Regional Nodal Irradiation With VMAT: Early Results of a Phase II Trial
Location: Room 214 C/D
Daphna Gelblum, MD, MS – Memorial Sloan Kettering Cancer Center
Monday, Oct 22
11:15 am
86 - Chest Wall Boost in Post-Mastectomy Radiation and the Impact on Reconstruction Complications
Location: Room 214 C/D
George Naoum, MD
Monday, Oct 22
11:25 am
87 - Association Between Radiographic Mastectomy Flap Thickness and Risk of Post-Radiation Therapy Breast Reconstruction Complication
Location: Room 214 C/D
Nitika Paudel, MD, PhD
Monday, Oct 22
11:35 am
88 - Comparing 10 Year Outcomes With Salvage Mastectomy Followed By Immediate Autologous Reconstruction or Tissue Expander/Implant Based Reconstruction in Patients With Locally Recurrent Breast Cancer After Breast Conservation Therapy
Location: Room 214 C/D
Bindu Manyam, MD
Monday, Oct 22
11:45 am
89 - Risk of Radiation Pneumonitis Following Individualized Modern Radiation Therapy With IMRT, a Breath-Holding Technique and Prone Positioning for Breast Cancer
Location: Room 214 C/D
Byung Min Lee, MD
Monday, Oct 22
11:55 am
90 - Comparing 10 Year Outcomes in Radiated Patients With Breast Autologous Reconstruction (AR) or Tissue Expander/Implant Based Reconstruction (TE/I)
Location: Room 214 C/D
Bindu Manyam, MD
Monday, Oct 22
12:05 pm
91 - Comparing Whole Heart Versus Coronary Artery Dosimetry in Predicting the Risk of Cardiac Toxicity Following Breast Radiation Therapy
Location: Room 214 C/D
Sagar Patel, MD – Harvard Radiation Oncology Program
Monday, Oct 22
4:15 pm
Update on the Genomic Profiling of Breast Cancer and Translating Such Research to Clinical Practice
Location: Room 302
Laura Esserman, MD
Monday, Oct 22
4:15 pm
Joint Session 03 (Live SA-CME) - ASTRO-ASCO Joint Session: Genomics to Personalize Breast Cancer Treatment: On the Evolving Road to Minimize Overtreatment
Location: Room 302
Peter Chen, MD, FACR, FASTRO – Oakland University William Beaumont School of Medicine
Monday, Oct 22
4:25 pm
Medical Oncology Therapeutics in the Landscape of Genomic Profiling of Breast Cancer
Location: Room 302
Douglas Yee
Monday, Oct 22
4:45 pm
Breast Surgical Oncology Decision-Making in the Era of Genomic Profiling of Breast Cancer
Location: Room 302
E. Shelley Hwang, MD, MPH
Monday, Oct 22
5:05 pm
Genomic Profiling of Breast Cancer and its Impact on Radiation Oncology Therapeutics
Location: Room 302
Abram Recht, MD, FASTRO
Monday, Oct 22
5:25 pm
Genomic Profiling for Radio-Sensitivity in Radiation Dose Selection for Breast Irradiation
Location: Room 302
Eleanor Harris, MD, FASTRO
Tuesday, Oct 23
7:45 am
132 - Pathogenic Mutations in ATM Enhance Radio-Sensitivity and Local Control in Patients With Primary and Metastatic Breast Cancer
Location: Room 214 A/B
Dana Casey, MD – Memorial Sloan Kettering Cancer Center
Tuesday, Oct 23
7:45 am
SS 21 - Breast 2 - Biology and SBRT
Location: Room 214 A/B
Corey Speers, MD, PhD, BS – University of Michigan; Rachel Blitzblau, MD, PhD
Tuesday, Oct 23
7:55 am
133 - Gene Expression Changes Predict Acute and Late Toxicity to Combined PARP1 Inhibition and Radiation (RT) in High Risk Breast Cancer Patients- Results of the Biomarker Analysis of TBCRC 024
Location: Room 214 A/B
Corey Speers, MD, PhD, BS – University of Michigan
Tuesday, Oct 23
8:05 am
134 - Locoregional Recurrence Is Associated With?Genomic Down-Regulation of the?Immune Response in Women With Locally Invasive Breast Cancer
Location: Room 214 A/B
Casey Liveringhouse, BA – Medical Student
Tuesday, Oct 23
8:15 am
135 - Minimal Increases in Tumor Infiltrating Lymphocytes Despite Excellent Tumor Responses After Pre-Operative Accelerated Partial Breast Irradiation in Early Stage ER+ Breast Cancer Patients
Location: Room 214 A/B
Carmen Bergom, MD, PhD – Medical College of Wisconsin
Tuesday, Oct 23
8:25 am
136 - Phase I Trial of Stereotactic Body Radiation Therapy(SBRT) to Multiple Metastatic Sites: A NRG Oncology Study
Location: Room 214 A/B
Steven Chmura, MD, PhD
Tuesday, Oct 23
8:35 am
137 - Results of a Prospective Cohort Trial: Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy (SIGNAL) for Early-Stage Breast Cancer
Location: Room 214 A/B
Brian Yaremko, MD, MSc, PEng
Tuesday, Oct 23
8:45 am
Scientific Discussant
Location: Room 214 A/B
Stephen Shiao, MD, PhD
Tuesday, Oct 23
1:00 pm
158 - Five-Year Results of a Prospective Phase 2 Trial Evaluating Three-Week Hypofractionated Whole Breast Radiation Therapy with Boost
Location: Room 303
Apar Gupta, MD, MBA
Tuesday, Oct 23
1:00 pm
SS 23 - Breast 3?- General
Location: Room 303
Anthony Dragun, MD – MD Anderson Cancer Center at Cooper; Melissa Mitchell, MD, PhD
Tuesday, Oct 23
1:10 pm
159 - Cancer-Specific Outcomes of Hypofractionated Locoregional Radiation Therapy for Patients With Stage I-III Breast Cancer
Location: Room 303
Theodora Koulis, MD
Tuesday, Oct 23
1:20 pm
160 - Technique and Preliminary Results of a Multi-Center Trial of Intra-Operative Radiation Therapy Using Electronic Brachytherapy at the Time of Breast Conserving Surgery for Early Stage Breast Cancer
Location: Room 303
Alam Syed, MD – LONG BEACH RADIATION ONCOLOGY MEDICAL GROUP
Tuesday, Oct 23
1:30 pm
161 - Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity-Score Matched Cohort Analysis
Location: Room 303
Jean Michel Hannoun Levi, MD, PhD
Tuesday, Oct 23
1:40 pm
162 - Influence of Hypofractionated Radiation Therapy Following Mastectomy on Complication in Breast Cancer Patients Undergoing Two-Stage Prosthetic Breast Reconstruction
Location: Room 303
Jeesuk Chang, MD – Yonsei Cancer Center
Tuesday, Oct 23
1:50 pm
163 - Two-Year Results of Once Daily Accelerated Partial Breast Irradiation: A Randomized Controlled Study
Location: Room 303
Rimoun Boutrus, MD, PhD
Tuesday, Oct 23
2:00 pm
164 - Using Clinical Pathways to Standardize Adoption of Hypofractionated Whole-breast Irradiation for Women Younger Than 50
Location: Room 303
Joshua Rodriguez-Lopez, MD
Tuesday, Oct 23
2:10 pm
165 - Role of Post Mastectomy Radiation Therapy Boost in Invasive Breast Cancer Patients. Is It Needed?
Location: Room 303
Mohamed Abouegylah, MD
Tuesday, Oct 23
2:20 pm
Scientific Discussant
Location: Room 303
Rachel Abrams Rabinovitch, MD, FASTRO – University of Colorado Denver
Tuesday, Oct 23
2:45 pm
TU_1_3323 - Outcomes and Toxicity of Stereotactic Radiation Therapy for Metastatic Breast Cancer - a Retrospective Cohort Study
Location: Innovation Hub, Exhibit Hall 3
Mark Niglas, MD, BS, FRCPC
Tuesday, Oct 23
2:45 pm
TU_1_3324 - The impact of postmastectomy radiation scar boost on local recurrence free survival in high risk patients
Location: Innovation Hub, Exhibit Hall 3
Ashley Albert, MD
Tuesday, Oct 23
2:45 pm
TU_1_3325 - Is Radiation Therapy Dose Escalation for Inflammatory Breast Cancer (IBC) Still Required With Modern Multi-Modality Treatment: A Multi-Institution Retrospective Review, 2000-2011
Location: Innovation Hub, Exhibit Hall 3
Rahul Arora, BS
Tuesday, Oct 23
2:45 pm
TU_1_3326 - Long-Term Results of Post mastectomy Conformal Electron Therapy Technique (PMERT) with bolus in comparison with Post mastectomy Conformal Photon Therapy (PMPhRT) without bolus in non-metastatic breast cancer patients
Location: Innovation Hub, Exhibit Hall 3
Youlia Kirova, MD
Tuesday, Oct 23
2:45 pm
TU_1_3327 - Patterns of Postmastectomy Radiation in Clinically Node Positive Breast Cancer Patients With Pathologically Negative Lymph Nodes After Neoadjuvant Chemotherapy
Location: Innovation Hub, Exhibit Hall 3
John Byun, MD – Cancer Institute of New Jersey
Tuesday, Oct 23
2:45 pm
TU_1_3328 - Characterization of the Tumor Microenvironment (TME) with Quantitative Multiplex Immunofluorescence (qMIF) in a cohort of Neoadjuvant Breast Cancer (BC) patients: a pilot analysis
Location: Innovation Hub, Exhibit Hall 3
Christine Chin, MD
Tuesday, Oct 23
2:45 pm
TU_1_3330 - Analysis of patterns of lymph node metastases in primary and recurrent breast cancer by evaluation of FDG / PET-CT image datasets
Location: Innovation Hub, Exhibit Hall 3
Julia Voppichler, PhD
Tuesday, Oct 23
2:45 pm
TU_1_3331 - Inverse Planning Intensity-Modulated Radiation Therapy in Chest Wall And Lymphatic Irradiation: Early Results
Location: Innovation Hub, Exhibit Hall 3
Melis Gultekin, RT
Tuesday, Oct 23
2:45 pm
TU_1_3332 - Evaluating the Dose to the Lower Posterior Cervical Lymph Nodes and Risk of Supraclavicular Failure in Regional Nodal Irradiation for Breast Cancer Using 3D-Conformal Radiation Therapy and Intensity Modulated Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Erin Healy, MD – The Ohio State University
Tuesday, Oct 23
2:45 pm
TU_1_3398 - Air Expander Implant Can Compromise Target Coverage and Dose Homogeneity of Post-Mastectomy Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Christine Chin, MD
Tuesday, Oct 23
2:45 pm
TU_2_3333 - Comparison of Conventional Dynamic IMRT Plan Versus Target Segmented Plan in Irradiation of Postmastectomy Patients
Location: Innovation Hub, Exhibit Hall 3
Jian Hu, MD
Tuesday, Oct 23
2:45 pm
TU_2_3334 - Effects of Trastuzumab on Locoregional Recurrence in Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Patients Treated With Chemotherapy and Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Seung Hyuck Jeon, MD
Tuesday, Oct 23
2:45 pm
TU_2_3336 - Breast Board Comined with a Thermoplastic Head Mask Immobilization Can Improve the Reproducibility of the Treatment Setup for Breast Cancer Patients Who Received Both Whole Breast and Supraclavicular Nodal Region Irradiation
Location: Innovation Hub, Exhibit Hall 3
Mingwei Ma, MD
Tuesday, Oct 23
2:45 pm
TU_2_3337 - How Should We Proceed With ypN+ Breast Cancer Following Positive Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy?
Location: Innovation Hub, Exhibit Hall 3
Chelsea Miller, MD
Tuesday, Oct 23
2:45 pm
TU_2_3338 - Proton Beam Therapy for Isolated Locoregional Recurrence of Breast Cancer after Mastectomy Without Prior Radiation Therapy: Prospective PCG Registry Analysis
Location: Innovation Hub, Exhibit Hall 3
Joshua Niska, MD
Tuesday, Oct 23
2:45 pm
TU_2_3339 - The Lack of Consensus of International Contouring Guidelines for the Dorsal Border of the Chest Wall Clinical Target Volume: What is the Impact on Organs at Risk and Relationships to Patterns of Recurrence in the Modern-Era?
Location: Innovation Hub, Exhibit Hall 3
Phillip Pifer, MD, PhD – WVU
Tuesday, Oct 23
2:45 pm
TU_2_3340 - Non-metastatic inflammatory breast cancer: A Surveillance, Epidemiology and End Results (SEER) Analysis
Location: Innovation Hub, Exhibit Hall 3
Stephen Shamp, MD
Tuesday, Oct 23
2:45 pm
TU_2_3341 - Early toxicity and patient reported outcomes of post-mastectomy pencil-beam scanning proton therapy in women with immediate tissue expander breast reconstruction
Location: Innovation Hub, Exhibit Hall 3
Na Smith, MD, PhD
Tuesday, Oct 23
2:45 pm
TU_2_3342 - Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach
Location: Innovation Hub, Exhibit Hall 3
Shane Stecklein, MD, PhD
Tuesday, Oct 23
2:45 pm
TU_3_3343 - Survival Outcomes for Breast Cancer Patients with Liver Metastases: A Population-Based Study of 3,549 Patients
Location: Innovation Hub, Exhibit Hall 3
Jaipreet Suri, MD
Tuesday, Oct 23
2:45 pm
TU_3_3344 - Risk factors of locoregional recurrence in patients with N2-3a breast cancer treated with post mastectomy radiation
Location: Innovation Hub, Exhibit Hall 3
Yu Tang, MD
Tuesday, Oct 23
2:45 pm
TU_3_3345 - Uptake of whole breast hypofractionation: a rapid review of the literature
Location: Innovation Hub, Exhibit Hall 3
Matthew Culbert, BS
Tuesday, Oct 23
2:45 pm
TU_3_3346 - Patient Reported Outcomes and Cosmesis Following Once Weekly Hypofractionated Breast Irradiation
Location: Innovation Hub, Exhibit Hall 3
Harriet Eldredge-Hindy, MD
Tuesday, Oct 23
2:45 pm
TU_3_3347 - Multi-institutional Registry Study of Accelerated Partial Breast Irradiation (APBI) Using Non-invasive Image-guided Breast Brachytherapy (NIBB)
Location: Innovation Hub, Exhibit Hall 3
Jaroslaw Hepel, MD
Tuesday, Oct 23
2:45 pm
TU_3_3348 - Short Course, Two Day Accelerated Hypofractionated Partial Breast Balloon Brachytherapy, a Phase II Multi-Institutional Trial
Location: Innovation Hub, Exhibit Hall 3
Jenna Kahn, MD – Virginia Commonwealth University Health System
Tuesday, Oct 23
2:45 pm
TU_3_3349 - A Prospective International Study on Safety and Efficacy of Hypofractionated Radiation Therapy for Post-Operative Breast Cancer Patients in Asian Countries
Location: Innovation Hub, Exhibit Hall 3
Kumiko Karasawa, MD, PhD
Tuesday, Oct 23
2:45 pm
TU_3_3350 - Hypofractionated Regional Nodal Irradiation (HF-RNI) in Early Breast Cancer (BC) after Breast-Conserving surgery (BCS): A single institution comparative study
Location: Innovation Hub, Exhibit Hall 3
Sahar ghith-Neji, MD
Tuesday, Oct 23
2:45 pm
TU_3_3351 - Local Recurrence Rates for Early Stage Breast Cancer Treated With Breast Conservation and Single Fraction IntraOperative Electron Radiation Therapy ( IOERT) at a Community Hospital
Location: Innovation Hub, Exhibit Hall 3
Venita Williams, MD
Tuesday, Oct 23
2:45 pm
TU_3_3379 - Regional Nodal Irradiation (RNI) in the Sentinel Lymph Node Biopsy (SLNB) Era: Comparison of Radiation Therapy (RT) Techniques that Involve Axillary Nodal Levels I-IV
Location: Innovation Hub, Exhibit Hall 3
Sahar ghith-Neji, MD
Tuesday, Oct 23
2:45 pm
TU_4_3353 - Secondary Breast Cancer after DCIS: Impact of Initial Radiation Therapy on Mortality Associated With Invasive Second Breast Cancers
Location: Innovation Hub, Exhibit Hall 3
Puyao Li, MD
Tuesday, Oct 23
2:45 pm
TU_4_3354 - Hypofractionated Partial Breast Irradiation after Breast-conserving Surgery for Patients with Low-risk Breast Cancer: Preliminary Safety Results in initial 50 Cases
Location: Innovation Hub, Exhibit Hall 3
Jinli Ma, MD
Tuesday, Oct 23
2:45 pm
TU_4_3355 - Outcomes in DCIS Patients Treated with Hypofractionated Whole Breast Radiation Therapy With Integrated Boost Compared to Standard Fractionation with Concomitant Boost
Location: Innovation Hub, Exhibit Hall 3
Jonathan Paly, DO
Tuesday, Oct 23
2:45 pm
TU_4_3356 - Improving Reproducibility and Inter-Rater Reliability for Lumpectomy Cavity Boost Contouring in Breast Cancer Patients Using a 3-D Bio-Absorbable Tissue Marker
Location: Innovation Hub, Exhibit Hall 3
Mustafa Abugideiri, MD
Tuesday, Oct 23
2:45 pm
TU_4_3357 - Temporal Trends in the Use of Immediate Oncoplastic Techniques in Women Undergoing Breast Conserving Surgery and Adjuvant Radiation
Location: Innovation Hub, Exhibit Hall 3
Jose Bazan, MD, MS
Tuesday, Oct 23
2:45 pm
TU_4_3358 - Utilization and Toxicity of Breast Boost Radiation Therapy Following Hypofractionated Whole Breast Irradiation: Comparative Analysis of a Large, Statewide Multicenter Cohort
Location: Innovation Hub, Exhibit Hall 3
Thomas Boike, MD
Tuesday, Oct 23
2:45 pm
TU_4_3359 - The optimal adjuvant treatment in older patients with hormone receptor positive early stage breast cancer (BC) is breast radiation (RT) not endocrine therapy (ET)
Location: Innovation Hub, Exhibit Hall 3
Manjeet Chadha, MD, FASTRO – Mount Sinai Beth Israel Medical Center
Tuesday, Oct 23
2:45 pm
TU_4_3360 - Post-Mastectomy Radiation Therapy in Stage II N1 Breast Cancer Patients Is Associated with Improved Survival with Different Sub-Type.
Location: Innovation Hub, Exhibit Hall 3
Wei-Kai Chuang, MD
Tuesday, Oct 23
2:45 pm
TU_4_3361 - Accelerated Partial Breast Irradiation Outcomes from a Tertiary Referral Community Hospital: Utilizing the Guidelines
Location: Innovation Hub, Exhibit Hall 3
Danielle Cunningham, MD
Tuesday, Oct 23
2:45 pm
TU_4_3363 - Increasing use of hypofractionated whole breast irradiation: an analysis of practice patterns within a state-wide quality consortium
Location: Innovation Hub, Exhibit Hall 3
Joshua Dilworth, MD, PhD – Beaumont Health System
Tuesday, Oct 23
2:45 pm
TU_5_3362 - Helical Tomotherapy (HT) for postmastectomy radiation therapy (PMRT) treatment after implant breast reconstruction
Location: Innovation Hub, Exhibit Hall 3
Romain Dejean
Tuesday, Oct 23
2:45 pm
TU_5_3364 - Disease Control and Survival Outcomes for Strut-Adjusted Volume Implant for Early-Stage Breast Cancer in ASTRO Consensus Guidelines Cautionary Groups for Accelerated Partial Breast Irradiation: A Single-Institution Experience
Location: Innovation Hub, Exhibit Hall 3
Kris Duriseti, MD, PhD
Tuesday, Oct 23
2:45 pm
TU_5_3366 - A Phase 2 Study of Hypofractionated Partial Breast Irradiation (HF-PBI) in Women with Early Stage Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
Penny Fang, MD, MBA
Tuesday, Oct 23
2:45 pm
TU_5_3367 - Accelerated Partial Breast Irradiation in Guideline-Defined Suitable and Cautionary Patients
Location: Innovation Hub, Exhibit Hall 3
Kelly Fitzgerald, MD, PhD
Tuesday, Oct 23
2:45 pm
TU_5_3368 - A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) with Prone Breast Irradiation
Location: Innovation Hub, Exhibit Hall 3
Naamit Gerber, MD – NYU Langone Medical Center
Tuesday, Oct 23
2:45 pm
TU_5_3369 - Prospective Study of 3-Fraction Intra-Cavitary Accelerated Partial Breast Brachytherapy: Early Provider and Patient-Reported Outcomes of a Novel Regimen
Location: Innovation Hub, Exhibit Hall 3
Krishan Jethwa, MD – Mayo Clinic
Tuesday, Oct 23
2:45 pm
TU_5_3370 - Long-term Subsequent Breast Cancer Risk and Overall Survival in Older Women with Estrogen Receptor Positive Early Stage Breast Cancer Treated in a Community Health Plan
Location: Innovation Hub, Exhibit Hall 3
Deborah Jiang, MD, MS
Tuesday, Oct 23
2:45 pm
TU_5_3371 - Evaluation of the Motion Range using Surface Mapping System during the Deep Inspiration Breath Hold for Left-Sided Breast Cancer Patients
Location: Innovation Hub, Exhibit Hall 3
Wenhuan Jiang, PhD
Tuesday, Oct 23
2:45 pm
TU_5_3372 - The Impact of Disparate Subtypes of Breast Cancer and Response to Postoperative Radiation Therapy in Neoadjuvant Setting
Location: Innovation Hub, Exhibit Hall 3
Kairui Jin, MD
Tuesday, Oct 23
2:45 pm
TU_6_3352 - Accelerated Partial Breast Irradiation with IORT in the Management of DCIS: A Single-Institution Experience in Patient Selection and Treatment Outcomes
Location: Innovation Hub, Exhibit Hall 3
Christine Chin, MD
Tuesday, Oct 23
2:45 pm
TU_6_3373 - A Multicenter Single-arm Confirmatory Trial on Hypofractionated Whole-breast Irradiation after Breast-conserving Surgery
Location: Innovation Hub, Exhibit Hall 3
Yoshifumi Kawaguchi, MD, PhD
Tuesday, Oct 23
2:45 pm
TU_6_3374 - Pre- and Intraoperative Factors Influencing Omission of Planned Intraoperative Radiation Therapy As a Boost for Breast Cancer Patients Undergoing Breast Conserving Treatment
Location: Innovation Hub, Exhibit Hall 3
Jun Won Kim, MD, PhD
Tuesday, Oct 23
2:45 pm
TU_6_3375 - Use of Preoperative Radiation Therapy in Early and Advanced Stage Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
Julie Koenig, BS
Tuesday, Oct 23
2:45 pm
TU_6_3376 - Patterns of Care of Adjuvant Radiation Therapy After Lumpectomy and Survival in T1N0M0 Estrogen Receptor Positive Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
Anna Lee, MD, MPH
Tuesday, Oct 23
2:45 pm
TU_6_3377 - External Validation of IBTR! 2.0 Nomogram for Prediction of Ipsilateral Breast Tumor Recurrence
Location: Innovation Hub, Exhibit Hall 3
Byung Min Lee, MD
Tuesday, Oct 23
2:45 pm
TU_6_3378 - Equivalent Outcomes for Accelerated Partial Breast Irradiation for Invasive Lobular Carcinoma: A Matched Pair Analysis
Location: Innovation Hub, Exhibit Hall 3
Ronald Levitin, MD, BS
Tuesday, Oct 23
2:45 pm
TU_6_3380 - OncotypeDX Risk Stratification in Early Stage Breast Cancer: When is Accelerated Partial Breast Irradiation (APBI) Safe?
Location: Innovation Hub, Exhibit Hall 3
Ashley Newman, MD
Tuesday, Oct 23
2:45 pm
TU_6_3381 - Patient Reported Outcomes From a Prospective Risk-Adapted Breast IORT Registry Trial
Location: Innovation Hub, Exhibit Hall 3
Jane Witter Ridings, MD
Tuesday, Oct 23
2:45 pm
TU_7_3383 - Concordance of Biomarkers and Tumor Location for in-Breast Tumor Recurrences in Early Stage Breast Cancer Patients Treated with Breast Conserving Surgery and Adjuvant RT
Location: Innovation Hub, Exhibit Hall 3
Juhi Purswani, BS
Tuesday, Oct 23
2:45 pm
TU_7_3384 - Once-Weekly Hypofractionated Radiation Therapy in Breast Cancer: A Phase 2 Trial
Location: Innovation Hub, Exhibit Hall 3
Lievin Reboucas, MD, PhD
Tuesday, Oct 23
2:45 pm
TU_7_3385 - Time-Driven Activity-Based Cost Analysis of CT-Guided Intraoperative High-Dose Rate Brachytherapy Versus Whole Breast Irradiation in the Treatment of Early Stage Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
Jason Sanders, MD, BS
Tuesday, Oct 23
2:45 pm
TU_7_3386 - Use of Three-dimensional Ultrasound for Daily Positioning in Patients Treated with Partial Breast Radiation Therapy: Results from a Prospective Clinical Trial
Location: Innovation Hub, Exhibit Hall 3
Mutlay Sayan, MD
Tuesday, Oct 23
2:45 pm
TU_7_3387 - Historical Trends of Implantable Accelerated Partial Breast Irradiation Usage after Breast Conserving Surgery for Stage I Breast Cancer: A SEER Analysis
Location: Innovation Hub, Exhibit Hall 3
Zaid Siddiqui, MD – Beaumont Health System
Tuesday, Oct 23
2:45 pm
TU_7_3388 - Breast Conservation Therapy Achieved Comparable Outcomes with Mastectomy in Patients with T1-2N0 Triple-Negative Breast Cancer: Analysis of 822 Patients in a Single Institution
Location: Innovation Hub, Exhibit Hall 3
Shulian Wang, MD
Tuesday, Oct 23
2:45 pm
TU_7_3389 - Does the Presence of a Bioabsorbable Device Sutured into the Cavity after Breast Conserving Surgery Effect Treatment Planning Targets for Breast Radiation?
Location: Innovation Hub, Exhibit Hall 3
Tamara Smith, MD
Tuesday, Oct 23
2:45 pm
TU_7_3390 - Mastectomy Without Radiation Therapy Had Inferior Outcomes As Compared to Breast Conserving Surgery or Mastectomy Plus Radiation Therapy in Patients With T1-2N1 Triple-Negative Breast Cancer: Analysis of 412 Patients in a Single Institution
Location: Innovation Hub, Exhibit Hall 3
Shulian Wang, MD
Tuesday, Oct 23
2:45 pm
TU_7_3391 - Risk-Adapted Postmastectomy Radiation Therapy for Patients with Clinical T1-2N0-1 Breast Cancer after Neoadjuvant Chemotherapy
Location: Innovation Hub, Exhibit Hall 3
Xin Wang, MD
Tuesday, Oct 23
2:45 pm
TU_7_3392 - Failure to Apply Eligibility Criteria per CALGB 9343 When Omitting Radiation Therapy Results in Excess Locoregional Failures in Elderly Breast Cancer Patients
Location: Innovation Hub, Exhibit Hall 3
Matthew Whitmill, BS
Tuesday, Oct 23
2:45 pm
TU_8_3329 - Post-Mastectomy Radiation Therapy (PMRT) in Women with T3N0 Breast Cancer: An Updated Surveillance, Epidemiology and End Results (SEER) Analysis
Location: Innovation Hub, Exhibit Hall 3
Nicholas Damico, MD
Tuesday, Oct 23
2:45 pm
TU_8_3393 - The Use of New Delineation Tool "MIRADA", Step-by-step Development and First Results of Its Use in Early Stage Breast Cancer Patients
Location: Innovation Hub, Exhibit Hall 3
Haoping Xu, MD, PhD
Tuesday, Oct 23
2:45 pm
TU_8_3394 - The Impact of Adjuvant Radiation Therapy in Elderly Patients with ER Positive, Early Stage Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
George Yang, MD
Tuesday, Oct 23
2:45 pm
TU_8_3395 - A Comparative Study on the Target Volumes Defined Using Preoperative Prone Magnetic Resonance Image and Postoperative Prone Computed Tomography Image Based Deformable Image Registration for External-Beam Partial Breast Irradiation
Location: Innovation Hub, Exhibit Hall 3
Ting Yu
Tuesday, Oct 23
2:45 pm
TU_8_3396 - Re-irradiation of Local-regional Disease in Breast Cancer Using Modern Radiation Techniques: Preliminary Results of Tolerability and Efficacy
Location: Innovation Hub, Exhibit Hall 3
Jose Bazan, MD, MS
Tuesday, Oct 23
2:45 pm
TU_8_3397 - Analyzes of FDG/PET-CT positive Lymph Node Metastases and Implications for Dose Delivery
Location: Innovation Hub, Exhibit Hall 3
Kai Borm, MD
Tuesday, Oct 23
2:45 pm
TU_8_3399 - Malignant and Borderline Phyllodes Tumors of the Breast Treated by Breast-Conserving Surgery Alone: Analysis of the Site and Histologic Grade of Ipsilateral Breast Tumor Recurrences (KROG 16-08)
Location: Innovation Hub, Exhibit Hall 3
Noorie Choi, MD
Tuesday, Oct 23
2:45 pm
TU_8_3400 - Does Deep Inspiration Breath Hold prolong life? Individual Risk Estimates of Ischemic Heart Disease After Breast Cancer Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Stefanie Corradini, MD
Tuesday, Oct 23
2:45 pm
TU_8_3401 - Nationwide Trends in Heart-Sparing Techniques Utilized in Radiation Therapy for Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
Nina Desai, MD
Tuesday, Oct 23
2:45 pm
TU_8_3402 - Radiation Therapy Planning and Phantom Dosimetry of a Novel Breast Tissue Expander
Location: Innovation Hub, Exhibit Hall 3
Benjamin Farnia, MD, BA
Tuesday, Oct 23
2:45 pm
TU_9_3403 - Tattoo Free Set-up for Partial Breast Irradiation: A Feasibility Study
Location: Innovation Hub, Exhibit Hall 3
Rachel Jimenez, MD
Tuesday, Oct 23
2:45 pm
TU_9_3404 - Set-up Reproducibility for Deep Inspiration Breath Hold for Left Sided Breast Cancer Treatment Using Daily Mega Voltage Imaging- Integrated Network Study
Location: Innovation Hub, Exhibit Hall 3
Hayeon Kim, PhD
Tuesday, Oct 23
2:45 pm
TU_9_3405 - Management of loco-regional recurrent breast cancer after prior radiation to the breast or chest wall
Location: Innovation Hub, Exhibit Hall 3
Christine Koch, MD, PhD
Tuesday, Oct 23
2:45 pm
TU_9_3406 - Coronary Calcium Burden in Breast Cancer Patients Receiving Adjuvant Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Yu-Hsuan Lai, MD
Tuesday, Oct 23
2:45 pm
TU_9_3407 - Biologic Subtypes of Primary Breast Tumors Exhibit Differences in the Radiosensitivity Index
Location: Innovation Hub, Exhibit Hall 3
Casey Liveringhouse, BA – Medical Student
Tuesday, Oct 23
2:45 pm
TU_9_3408 - A Reliable Nomogram for Predicting Overall Survival in Patients with Triple-Negative Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
Mingwei Ma, MD
Tuesday, Oct 23
2:45 pm
TU_9_3409 - Assessing Quality of Heart Contouring and Dosimetry in Treatment of Left Sided Breast Cancer Across Cancer Centers within an Integrated Health System
Location: Innovation Hub, Exhibit Hall 3
Bindu Manyam, MD
Tuesday, Oct 23
2:45 pm
TU_9_3410 - What target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network - meta-analysis
Location: Innovation Hub, Exhibit Hall 3
Christiane Matuschek, MD
Tuesday, Oct 23
2:45 pm
TU_9_3411 - Intraoperative Radiation Therapy (IORT) As Sole Adjuvant RT Modality for Breast Cancer: Patterns of Care in the United States and Utilization After Publication of Guidelines and Randomized Trials
Location: Innovation Hub, Exhibit Hall 3
Christopher Morrison, MD, PhD
Tuesday, Oct 23
2:45 pm
TU_9_3412 - Patterns of Care and Predictors of Adjuvant Radiation Therapy in Phyllodes Tumor of the Breast
Location: Innovation Hub, Exhibit Hall 3
Oluwadamilola Oladeru, MD, BS, MA
Tuesday, Oct 23
2:45 pm
TU_10_3413 - Biologic Subtypes as a Predictor of Local Control of Breast Cancer Brain Metastases after Stereotactic Radiosurgery
Location: Innovation Hub, Exhibit Hall 3
Lucas Resende Salgado, MD
Tuesday, Oct 23
2:45 pm
TU_10_3414 - Identifying Survivorship Needs Among Women with Breast Cancer after Receiving Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Kiri Sandler, MD – UCLA
Tuesday, Oct 23
2:45 pm
TU_10_3415 - A Within Subject Study Comparing Utility and Comfort of Breast Board Immobilization with Vacuum Bag for Radiation Therapy in Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
Balu Krishna Sasidharan, MD, MBBS, DNB DMRT
Tuesday, Oct 23
2:45 pm
TU_10_3416 - Internal mammary lymph nodes involvement in patients with breast cancer: anatomical characteristics and implication for target definition
Location: Innovation Hub, Exhibit Hall 3
Yujie Wang
Tuesday, Oct 23
2:45 pm
TU_10_3417 - Pattern of Clavicular Lymph Nodes Metastases and its Implication in Clinical Target Volume Delineation for Patients with Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
Xueqing Zhang, BS
Tuesday, Oct 23
2:45 pm
TU_10_3418 - Acute Toxicity Outcomes and Dosimetric Implications from Incidental Irradiation of Adjacent Tissues in Tangent Field Hypofractionated Breast Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Sara Alcorn, MD, MPH
Tuesday, Oct 23
2:45 pm
TU_10_3419 - Risk of cardiac disease after adjuvant radiation therapy among breast cancer survivors
Location: Innovation Hub, Exhibit Hall 3
Jeesuk Chang, MD – Yonsei Cancer Center
Tuesday, Oct 23
2:45 pm
TU_10_3420 - Long-Term Incidence Rate of Coronary Heart Disease in Breast Cancer Patients - A Population Based Study
Location: Innovation Hub, Exhibit Hall 3
Ying-Hsiang Chou, MD, MBA
Tuesday, Oct 23
2:45 pm
TU_10_3421 - Does Deep Inspiration Breath Hold (DIBH) Impact Dose to Coronary Arteries During Postmastectomy Electron Boost Treatment?
Location: Innovation Hub, Exhibit Hall 3
James Coster, MD
Tuesday, Oct 23
2:45 pm
TU_10_3422 - Comparison of Acute Skin Toxicities in Breast Cancer Patients Undergoing Adjuvant Proton vs. Photon Radiation Therapy: A single institutional experience
Location: Innovation Hub, Exhibit Hall 3
Cristina DeCesaris, MD
Tuesday, Oct 23
2:45 pm
TU_11_3423 - Assessment of Cardiac Dosimetry and Additional Cardiac Risk Factors in Patients Undergoing Modern Breast Cancer Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Christopher Fleming, MD
Tuesday, Oct 23
2:45 pm
TU_11_3424 - A Simple Cardiac Sparing Strategy for Left Breast Radiation Therapy Using Right Semi-Decubitus Positioning
Location: Innovation Hub, Exhibit Hall 3
Claire Fung, MD, MS – Beth Israel Deaconess Medical Center
Tuesday, Oct 23
2:45 pm
TU_11_3425 - Incidence of Breast Lymphedema and Predictors of its Development in Patients Receiving Whole Breast Radiation Therapy Alone after Breast-Conservation Surgery
Location: Innovation Hub, Exhibit Hall 3
Rohit Ganju, MD
Tuesday, Oct 23
2:45 pm
TU_11_3426 - Randomized, Prospective, Open-Label Phase III Trial Comparing β-Sitosterol (mebo) Ointment with Trolamine (biafine) Cream for the Management of Acute Skin Reaction during Radiation Therapy for Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
Fady Geara, MD, PhD
Tuesday, Oct 23
2:45 pm
TU_11_3427 - Palbociclib Enhances Pulmonary Fibrosis in Patients Undergoing Thoracic Radiation Therapy: A Case Series and Review of the Literature
Location: Innovation Hub, Exhibit Hall 3
Ronny Kalash, DO
Tuesday, Oct 23
2:45 pm
TU_11_3428 - Dosimetric Benefits of Continuous Positive Airway Pressure Instead of Free-Breathing during Radiation Therapy for Breast Cancer Patients With Favorable, Unfavorable, and Challenging Cardiac-Thoracic Anatomy
Location: Innovation Hub, Exhibit Hall 3
Whoon Jong Kil, MD
Tuesday, Oct 23
2:45 pm
TU_11_3429 - Increased Risk of Varicella-Zoster Virus Infection in Breast Cancer Patients Treated With Adjuvant Radiation Therapy - A Population Based Cohort Study
Location: Innovation Hub, Exhibit Hall 3
hsin-yi cheng, MD
Tuesday, Oct 23
2:45 pm
TU_11_3430 - Dosimetric Parameters Correlated with Acute and Chronic Toxicity from Single Entry Applicator Accelerated Partial Breast Irradiation
Location: Innovation Hub, Exhibit Hall 3
Hong-yiou Lin, MD, PhD – Beaumont Health
Tuesday, Oct 23
2:45 pm
TU_11_3431 - Novel Hyaluronan Formulation for Preventing Acute Skin Reactions in Breast During Radiation Therapy: A Randomized Clinical Trial
Location: Innovation Hub, Exhibit Hall 3
Osama Mohamad, MD, PhD – UTSW
Tuesday, Oct 23
2:45 pm
TU_11_3432 - Dosimetric Comparison of Deep Inspiration Breath-Hold versus Free Breathing for Right-Sided Breast Cancer with Comprehensive Nodal Radiation
Location: Innovation Hub, Exhibit Hall 3
Ram Narayan, MD
Tuesday, Oct 23
2:45 pm
TU_12_3433 - Comparative Outcome Analysis of Two Dose Schedules for Post-Mastectomy Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Reginald Nguyen, BS
Tuesday, Oct 23
2:45 pm
TU_12_3434 - Nasal Colonization With Staphylococcus Aureus Before Radiation Therapy Predicts Radiation Dermatitis: A Prospective Study
Location: Innovation Hub, Exhibit Hall 3
Alexandra Rzepecki, BS
Tuesday, Oct 23
2:45 pm
TU_12_3435 - The Impact of Chemotherapy on Toxicity and Cosmetic Outcome in Patients Receiving Hypofractionated Whole Breast Irradiation
Location: Innovation Hub, Exhibit Hall 3
Jane Spann, BS
Tuesday, Oct 23
2:45 pm
TU_12_3436 - Changes in Cardiac MRI Derived Left Ventricular Segmental Strain in Left Sided Breast Cancer Patients Treated With Tangential Radioation Therapy Alone Correlated With Dose
Location: Innovation Hub, Exhibit Hall 3
Simon Tang, MD, MBBS
Tuesday, Oct 23
2:45 pm
TU_12_3437 - Proton Beam Therapy Reirradiation for Recurrent Breast Cancer: Multi-Institutional Prospective PCG Registry Analysis
Location: Innovation Hub, Exhibit Hall 3
Cameron Thorpe, MD
Tuesday, Oct 23
2:45 pm
TU_12_3438 - Left Anterior Descending Coronary Artery Dose-Sparing Effects of Volumetric Modulated Arc Therapy in Patients Ineligible for Deep-Inspiration Breath-Hold in Left Breast Radiation Therapy.
Location: Innovation Hub, Exhibit Hall 3
Bartlomiej Tomasik, MD
Tuesday, Oct 23
2:45 pm
TU_12_3439 - Radiation Therapy Significantly Contributes to Loss of Cardiac Function After Treatment for Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
Veerle van den Bogaard, MD
Tuesday, Oct 23
2:45 pm
TU_12_3440 - Radiation effect on late cardiopulmonary toxicity: an analysis comparing DIBH versus prone techniques for breast treatment
Location: Innovation Hub, Exhibit Hall 3
Sherry Yan, MD
Tuesday, Oct 23
4:45 pm
Single-Fraction Upfront Treatment of Breast Cancer
Location: Room 006
Rachel Blitzblau, MD, PhD
Tuesday, Oct 23
4:45 pm
Panel 08 - The Radiobiological Bases of Novel Radiation Treatment Schemes for Breast Cancer
Location: Room 006
Peter Chen, MD, FACR, FASTRO – Oakland University William Beaumont School of Medicine
Tuesday, Oct 23
5:25 pm
Hypofractionation for Whole Breast Irradiation in 5 days (Fast Forward Trial)
Location: Room 006
Adrian Murray Brunt, MBBS, FRCR, FRCP
Tuesday, Oct 23
5:45 pm
The Radiobiology of Innovative Modes of Breast Cancer Treatment: From Tumor Microenvironment to Normal Tissue Effects
Location: Room 006
George Wilson, PhD – William Beaumont Hospital
Wednesday, Oct 24
7:45 am
Scientific Discussant
Location: Room 304
Alice Ho, MD – Cedars Sinai Medical Center
Wednesday, Oct 24
7:45 am
SH 05 - Science Highlights - Breast Cancer
Location: Room 304
Wednesday, Oct 24
11:00 am
Panelist - Medical Oncology Perspective
Location: Room 303
Carlos Barcenas, MD
Wednesday, Oct 24
11:00 am
EDU 38 - (INTERACTIVE) Challenging Cases in the Management of Breast Cancer
Location: Room 303
Gary Freedman, MD
Wednesday, Oct 24
11:17 am
Panelist - Surgical Oncology Perspective
Location: Room 303
E. Shelley Hwang, MD, MPH
Wednesday, Oct 24
11:34 am
Panelist - Radiation Oncology Perspective
Location: Room 303
Abram Recht, MD, FASTRO
Wednesday, Oct 24
11:51 am
Panelist - Radiation Oncology Perspective
Location: Room 303
Catherine Park, MD, FASTRO – University of California, San Francisco
Wednesday, Oct 24
12:08 pm
Panelist - International Radiation Oncology Perspective
Location: Room 303
Yazid Belkacemi, MD, PhD – Henri Mondor Univsrsity Hospital and Faculte de Medecin de Creteil Paris XII
Wednesday, Oct 24
12:25 pm
Audience Q&A
Location: Room 303
Gary Freedman, MD
Wednesday, Oct 24
1:30 pm
1144 - Final Results of Phase I Study of Prophylactic Nipple-Areola Complex Radiation Therapy After Nipple Sparing Mastectomy and Immediate Reconstruction for Breast Cancer or DCIS Patients
Location: Room 217 A/B
Cristiane Takita, MD, MBA
Wednesday, Oct 24
1:30 pm
PD 17 - Breast 4 -Poster Discussion
Location: Room 217 A/B
Wednesday, Oct 24
1:36 pm
1145 - Hypofractionated Radiation is Associated With Less Long-Term Breast Retraction Following Breast Conserving Therapy
Location: Room 217 A/B
Di Wang, BS
Wednesday, Oct 24
1:42 pm
1146 - Postoperative Single-Fraction Partial Breast Irradiation for Low-Risk Stage 0 and I Breast Carcinomas: Results of a Prospective Clinical Trial
Location: Room 217 A/B
William Kennedy, MD
Wednesday, Oct 24
1:48 pm
1147 - The Role of Neo-Bioscore Staging System in Optimizing the Strategies for Regional Nodes Irradiation Following Neoadjuvant Chemotherapy in Breast Cancer Patients With cN1 and ypN0-1
Location: Room 217 A/B
Lu Cao, MD
Wednesday, Oct 24
1:54 pm
1148 - Nomogram-Based Estimate of Axillary Nodal Involvement in ACOSOG Z0011 (Alliance): Validation and Association With Radiation Protocol Variations and Outcomes
Location: Room 217 A/B
Matthew Katz, MD, FASTRO
Wednesday, Oct 24
2:00 pm
1149 - Can Radiation Therapy Be Omitted After Breast Conserving Surgery With or Without Chemotherapy for Older Women (> 70 years old) With Early Stage Triple-Negative Breast Cancer?
Location: Room 217 A/B
Waqar Haque, MD
Wednesday, Oct 24
2:06 pm
1150 - Hypofractionated Whole Breast Irradiation in Large-Breasted Women - Is There A Predictor for Acute Skin Toxicity?
Location: Room 217 A/B
Ankur Patel, MD
Wednesday, Oct 24
2:12 pm
1152 - Outcome and Patterns of Failure in Breast Cancer Patients With FDG-PET Positive Internal Mammary Lymph Nodes: A Multicenter Rare Cancer Network Study
Location: Room 217 A/B
Gamze Ugurluer, MD
Wednesday, Oct 24
2:18 pm
1151 - Prone Partial Breast Irradiation (PBI): Prospective Randomized Trial to Compare Five Versus Three Fractions
Location: Room 217 A/B
Kimberly Thomas
Wednesday, Oct 24
2:24 pm
Scientific Discussant
Location: Room 217 A/B
Simona Shaitelman, MD, EdM
Wednesday, Oct 24
2:37 pm
Scientific Discussant
Location: Room 217 A/B
Mylin Torres, MD – Emory University
Saturday, Oct 20
9:00 am
Introduction
Location: Room 304
Richard Lovett, MD, FASTRO
Saturday, Oct 20
9:00 am
PRO 01 - (INTERACTIVE) PRO - Breast Cancer
Location: Room 304
Richard Lovett, MD, FASTRO – University of Vermont
Saturday, Oct 20
9:05 am
Breast Cancer- To Treat or Not to Treat
Location: Room 304
Jennifer Harper, MD
Saturday, Oct 20
9:30 am
Breast Cancer-Techniques and Volumes of Treatment/ Hypofractionation
Location: Room 304
Jean Wright, MD – Sibley Memorial Hospital
Saturday, Oct 20
9:55 am
Breast Cancer- Post mastectomy treatment and ASTRO Guidelines
Location: Room 304
Gary Freedman, MD
Saturday, Oct 20
10:20 am
Audience Q&A
Location: Room 304
Richard Lovett, MD, FASTRO
Sunday, Oct 21
10:45 am
Meet the Expert - Breast
Location: ASTRO Connect: Breast #423
Abram Recht, MD, FASTRO
Sunday, Oct 21
10:45 am
MTE 12 - Meet The Expert Abram Recht, MD, FASTRO - Breast - Sunday
Sunday, Oct 21
1:45 pm
Meet the Expert - Breast
Location: ASTRO Connect: Breast #423
Julia White, MD, FASTRO
Sunday, Oct 21
1:45 pm
MTE 17 - Meet The Expert Julia White, MD FASTRO - Breast - Sunday
Sunday, Oct 21
4:15 pm
Meet the Expert - Breast
Location: ASTRO Connect: Breast #423
Jennifer Bellon, MD, FASTRO – Dana-Farber Cancer Institute
Sunday, Oct 21
4:15 pm
MTE 22 - Meet The Expert Jennifer Bellon, MD, FASTRO - Breast - Sunday
Monday, Oct 22
11:15 am
MTE 27 - Meet The Expert Atif Khan, PhD - Breast - Monday
Monday, Oct 22
4:15 pm
Meet the Expert - Breast
Location: ASTRO Connect: Breast #423
Rachel Jimenez, MD
Monday, Oct 22
4:15 pm
MTE 32 - Meet The Expert Rachel Jimenez, MD - Breast - Monday
Tuesday, Oct 23
10:45 am
Meet the Expert - Breast
Location: ASTRO Connect: Breast #423
Steven Chmura, MD, PhD
Tuesday, Oct 23
10:45 am
MTE 37 - Meet The Expert Steven Chmura, MD, PhD - Breast - Tuesday
Tuesday, Oct 23
1:30 pm
Meet the Expert - Breast
Location: ASTRO Connect: Breast #423
Corey Speers, MD, PhD, BS – University of Michigan
Tuesday, Oct 23
1:30 pm
MTE 42 - Meet The Experts Corey Speers, MD, PhD, BS and Reshma Jagsi, MD, PhD, FASTRO - Breast - Tuesday
Tuesday, Oct 23
1:52 pm
Meet the Expert - Breast
Location: ASTRO Connect: Breast #423
Reshma Jagsi, MD, PhD, FASTRO – University of Michigan
Tuesday, Oct 23
3:15 pm
Meet the Expert - Breast
Location: ASTRO Connect: Breast #423
Dana Casey, MD – Memorial Sloan Kettering Cancer Center
Tuesday, Oct 23
3:15 pm
MTE 47 - Meet The Experts Dana Casey, MD and Nadeem Riaz, MD, PhD, FASTRO - Breast - Tuesday
Tuesday, Oct 23
4:15 pm
Meet the Expert - Breast
Location: ASTRO Connect: Breast #423
Gary Freedman, MD
Tuesday, Oct 23
4:15 pm
MTE 52 - Meet The Expert Gary Freedman, MD - Breast - Tuesday
Central Nervous System
Sunday, Oct 21
1:15 pm
Indications for WBRT vs. SRS in the Management of Multiple Brain Metastases
Location: Room 304
Eric Chang, MD, FASTRO – Keck School of Medicine of USC
Sunday, Oct 21
1:15 pm
EDU 01 (Live SA-CME) - The Modern Management of Brain Metastases
Location: Room 304
Yoshiya Yamada, MD, FRCPC – Memorial Sloan Kettering Cancer Center
Sunday, Oct 21
1:35 pm
Combining SRS/WBRT with immunotherapy/targeted therapy for brain metastases
Location: Room 304
John Fiveash, MD – University of Alabama Birmingham
Sunday, Oct 21
1:55 pm
Reirradiation of brain metastases; Management of local failures
Location: Room 304
Jonathan Knisely, MD, FASTRO – Weill Cornell Medical College
Sunday, Oct 21
2:15 pm
Indications for Single Fraction vs. Fractionated SRS in the treatment of Brain Metastases
Location: Room 304
Yoshiya Yamada, MD, FRCPC – Memorial Sloan Kettering Cancer Center
Sunday, Oct 21
4:45 pm
1018 - The Diagnosis and Comprehensive Treatment of Leptomeningeal Metastasis: A Phase II Trial
Location: Room 217 A/B
Siran Yang, MD
Sunday, Oct 21
4:45 pm
PD 03 - CNS 1 - Poster Discussion - Toxicity and Quality of Life
Location: Room 217 A/B
Sunday, Oct 21
4:51 pm
1019 - Whole Brain Re-irradiation Using Pulsed Reduced Dose Rate
Location: Room 217 A/B
Adam Burr, MD, PhD
Sunday, Oct 21
4:57 pm
1020 - Early Diffusion Imaging Biomarkers of Prefrontal Lobe White Matter Microstructural Damage are Associated With Executive Dysfunction Following Radiation Therapy in Patients With Primary Brain Tumors: A Prospective, Longitudinal Study
Location: Room 217 A/B
Kathryn Tringale, MD, MS – UCSD School of Medicine
Sunday, Oct 21
5:03 pm
1021 - Impact of Corticosteroids on the Efficacy of Anti-PD-1 Therapy for Tumors Located Within or Outside the Central Nervous System
Location: Room 217 A/B
Russell Maxwell, MD
Sunday, Oct 21
5:09 pm
1022 - Effects of Tumor Treating Fields (TTFields) on Health-Related Quality of Life (HRQoL) in Newly Diagnosed Glioblastoma: An Exploratory Analysis of the EF-14 Randomized Phase III Trial
Location: Room 217 A/B
Steven Toms, MD
Sunday, Oct 21
5:15 pm
1023 - TRAIT (Treatment-Related Alterations In Thinking): A Prospective Longitudinal Study Assessing Mild Cognitive Impairment in Irradiated Brain Tumor Patients
Location: Room 217 A/B
Christina Cramer, MD – Wake Forest Baptist Medical Center
Sunday, Oct 21
5:21 pm
1024 - Dosimetric Predictors of Cognitive Decline in Attention and Processing Speed After Fractionated Brain Radiation Therapy
Location: Room 217 A/B
Minh-Phuong Huynh-Le, MD – University of California, San Diego
Sunday, Oct 21
5:27 pm
1025 - One-Week Chemoradiotherapy is Associated With Less Treatment-Related Lymphopenia Compared to a Standard?Treatment?Course for Newly Diagnosed Glioblastoma
Location: Room 217 A/B
Dylann Fujimoto, BS
Sunday, Oct 21
5:33 pm
1026 - Adverse Radiation Effect following Repeat Stereotactic Radiosurgery for Brain Metastases
Location: Room 217 A/B
Jason Chan, MD – UCSF Radiation Oncology
Sunday, Oct 21
5:52 pm
Scientific Discussant
Location: Room 217 A/B
Mark Stavas, MD
Monday, Oct 22
10:45 am
MO_1_2455 - Quality of Life, Survival, and Recurrence Patterns following Adjuvant Stereotactic Radiosurgery for Resected Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
Jessica Arden, MD, PhD
Monday, Oct 22
10:45 am
MO_1_2458 - Subventricular Zone (SVZ) Radiation Dose and Outcomes in Patients with Glioblastoma Multiforme (GBM)
Location: Innovation Hub, Exhibit Hall 3
Huma Chaudhry, MD
Monday, Oct 22
10:45 am
MO_1_2472 - Interplay of Age and Performance Status on Patterns of Care and Outcomes in Elderly Patients with Glioblastoma: A National Cancer Database Analysis
Location: Innovation Hub, Exhibit Hall 3
Karine Al Feghali, MD, MS
Monday, Oct 22
10:45 am
MO_1_2473 - Stereotactic intracranial ablative radiation therapy for brain metastases with a mono-isocenter no-coplanar dedicated system: A preliminary dosimetric and clinical report
Location: Innovation Hub, Exhibit Hall 3
Filippo Alongi, MD, PROF – Sacro Cuore Don Calabria CANCER CARE CENTER
Monday, Oct 22
10:45 am
MO_1_2478 - Risk of visual toxicity following fractionated proton vs photon radiation therapy for patients with meningiomas
Location: Innovation Hub, Exhibit Hall 3
Andrew Bishop, MD
Monday, Oct 22
10:45 am
MO_1_2481 - A Population-Based Study of Melanoma Brain Metastasis Treatment: Has Progress in Systemic Therapy and Radiation Therapy Improved Patient Outcomes?
Location: Innovation Hub, Exhibit Hall 3
Harry Brastianos, MD, PhD, BS
Monday, Oct 22
10:45 am
MO_1_2483 - Post-operative cavity radiation therapy with standard fractionation for brain metastases
Location: Innovation Hub, Exhibit Hall 3
James Byrne, MD, PhD
Monday, Oct 22
10:45 am
MO_1_2486 - Initial Findings of Analysis of Circulating Tumor Cells in Patients with Brain Metastases of Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
Douglas Castro, MD
Monday, Oct 22
10:45 am
MO_1_2487 - Assessing the Impact of Pre-Treatment White Matter Hyperintensities on Cognitive Function After Whole Brain Radiation Therapy (WBRT)
Location: Innovation Hub, Exhibit Hall 3
Matthew Chan, MD
Monday, Oct 22
10:45 am
MO_1_2488 - Reirradiation of Recurrent High Grade Gliomas: Outcomes and Prognostic Factors
Location: Innovation Hub, Exhibit Hall 3
Christopher Chapman, MD, MS
Monday, Oct 22
10:45 am
MO_2_2492 - Clinical Outcomes and Safety Profile of Salvage External Beam Radiation Therapy and Re-Irradiation for Recurrent Atypical Meningioma
Location: Innovation Hub, Exhibit Hall 3
William Chen, BS
Monday, Oct 22
10:45 am
MO_2_2493 - Extent of Resection Is Potent Prognostic Factor Next to Molecular Pathologic Subtype in Low-Grade Glioma
Location: Innovation Hub, Exhibit Hall 3
Jinhyun Choi, MD
Monday, Oct 22
10:45 am
MO_2_2495 - The effect of low dose radiation on Alzheimer's disease-induced TG mice
Location: Innovation Hub, Exhibit Hall 3
Se young Choi, MS
Monday, Oct 22
10:45 am
MO_2_2496 - Radiosurgery and Checkpoint Blockade Confer Pathologic Complete Response in Mouse Glioblastoma Multiforme with Distinct Immunologic and Radiographic Signatures
Location: Innovation Hub, Exhibit Hall 3
Mariano Clausi, PhD
Monday, Oct 22
10:45 am
MO_2_2497 - A Retrospective Review on Stereotactic Radiosurgery Cases Planned with Dynamic Conformal Arcs Versus Volumetric Modulated Arc Therapy
Location: Innovation Hub, Exhibit Hall 3
Yunfeng Cui, PhD
Monday, Oct 22
10:45 am
MO_2_2498 - Outcomes in BRAF
V600e
-mutant melanoma brain metastases managed with radiosurgery: a multi-institutional assessment of craniotomy mitigation
Location: Innovation Hub, Exhibit Hall 3
Salah Dajani, MS
Monday, Oct 22
10:45 am
MO_2_2502 - Ocular Brachytherapy for Intra-ocular Melanoma: Experience and Outcomes in The Province of Alberta
Location: Innovation Hub, Exhibit Hall 3
Deepak Dinakaran, MD, (PhD)
Monday, Oct 22
10:45 am
MO_2_2503 - Consensus Guidelines for Target Volume Definition of the Sacrum in Spinal Stereotactic Body Radiation Therapy (SBRT)
Location: Innovation Hub, Exhibit Hall 3
Emma Dunne, PhD, MBBS, FRCR
Monday, Oct 22
10:45 am
MO_3_2490 - Prognostic and functional characterization of AQP1 and AQP4 in patients with glioma based on TCGA database
Location: Innovation Hub, Exhibit Hall 3
Mei hua Chen, MD
Monday, Oct 22
10:45 am
MO_3_2509 - Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated with anti-PD-1 Therapy
Location: Innovation Hub, Exhibit Hall 3
Muhammad Fareed, MD, FCPS
Monday, Oct 22
10:45 am
MO_3_2514 - Hippocampal sparing preserves neurocognitive functions in patients of Pituitary adenoma treated with IG-IMRT technique.
Location: Innovation Hub, Exhibit Hall 3
Utpal Gaikwad, MD, MBBS
Monday, Oct 22
10:45 am
MO_3_2515 - National Practice Patterns of Proton versus Photon Therapy in the Treatment of Adult Patients with Primary Brain Tumors
Location: Innovation Hub, Exhibit Hall 3
Vaishnavi Ganesan
Monday, Oct 22
10:45 am
MO_3_2520 - Phase II Prospective Trial to Assess the Feasibility and Efficacy of Dynamic 24Gy Single Dose Ablative Stereotactic Radiation Therapy in Oligometastatic Human Cancer
Location: Innovation Hub, Exhibit Hall 3
Carlo Greco, MD, MD
Monday, Oct 22
10:45 am
MO_3_2521 - A Single-Centre Prospective Assessment of Mask Versus Frame Fixation during Gamma Knife Treatment for Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
Mario Grimm
Monday, Oct 22
10:45 am
MO_3_2522 - Safety of Tumor Treating Fields and Concomitant Radiation Therapy for Newly Diagnosed Glioblastoma in a Pilot Study
Location: Innovation Hub, Exhibit Hall 3
Rachel Grossman, MD
Monday, Oct 22
10:45 am
MO_3_2527 - Temporalis Muscle Width as a Measure of Sarcopenia Independently Predicts Overall Survival in Patients with Newly Diagnosed Glioblastoma
Location: Innovation Hub, Exhibit Hall 3
Kristin Hsieh, BA
Monday, Oct 22
10:45 am
MO_3_2529 - Impact of Corticosteroid Use During Chemoradiotherapy on Lymphopenia and Survival of Glioblastoma Patients
Location: Innovation Hub, Exhibit Hall 3
Caressa Hui, BS – Washington University School of Medicine Department of Radiation Oncology
Monday, Oct 22
10:45 am
MO_3_2530 - Atypical histopathological features and the risk of progression/recurrence in WHO grade I-II meningiomas
Location: Innovation Hub, Exhibit Hall 3
William Hwang, MD, PhD – Massachusetts General Hospital
Monday, Oct 22
10:45 am
MO_4_2531 - Elucidation of an Exquisite Synergistic Interaction Between ATR Inhibitors and Alkylating Agents in MGMT-Methylated Glioma cells
Location: Innovation Hub, Exhibit Hall 3
Christopher Jackson, BS
Monday, Oct 22
10:45 am
MO_4_2532 - Evolving National Practice Patterns of Hypofractionated Stereotactic Radiation Therapy Versus Single-Fraction Radiosurgery for Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
Vikram Jairam, MD – Yale-New Haven Hospital
Monday, Oct 22
10:45 am
MO_4_2534 - Stereotactic Radiosurgery for Brain Metastases of Small Cell Lung Cancer at Diagnosis: Local Management Patterns
Location: Innovation Hub, Exhibit Hall 3
Wei Jiang, MD
Monday, Oct 22
10:45 am
MO_4_2535 - Safety and clinical outcomes of ipilimumab and nivolumab plus concurrent stereotactic radiosurgery for brain metastases
Location: Innovation Hub, Exhibit Hall 3
Christopher Johnson, MD, PhD
Monday, Oct 22
10:45 am
MO_4_2541 - Safety, efficacy, and setup accuracy of patients undergoing multi-level spine stereotactic radiosurgery
Location: Innovation Hub, Exhibit Hall 3
William Jackson, MD – University of Michigan
Monday, Oct 22
10:45 am
MO_4_2545 - The Clinical Results of Radiation Therapy for Spinal Cord Ependymoma with Adverse Prognostic Features: A Single-Institution Experience
Location: Innovation Hub, Exhibit Hall 3
Hwa Kyung Byun, MD
Monday, Oct 22
10:45 am
MO_4_2548 - High-dose radiation therapy is needed for intracranial control and long-term survival in patients with non-seminomatous germ cell tumor brain metastases
Location: Innovation Hub, Exhibit Hall 3
Dana Casey, MD – Memorial Sloan Kettering Cancer Center
Monday, Oct 22
10:45 am
MO_4_2549 - A Novel Fractionated Regimen Using Stereotactic Radiosurgery for Trigeminal Neuralgia
Location: Innovation Hub, Exhibit Hall 3
Serguei Castaneda, MD
Monday, Oct 22
10:45 am
MO_4_2558 - Comparison of Treatment Modalities for Large Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
Ammoren Dohm, BS
Monday, Oct 22
10:45 am
MO_4_2559 - Neuroanatomical differences in the brains of cerebral metastasized breast cancer patients:meningeal carcinomatosa patients vs. brain oligometastatic patients vs. multiple metastastic brain patients
Location: Innovation Hub, Exhibit Hall 3
Antonia Reibelt, PhD
Monday, Oct 22
10:45 am
MO_5_2564 - Single Fraction Spine Stereotactic Radiosurgery for Epidural Tumors
Location: Innovation Hub, Exhibit Hall 3
Erinma Elibe, BS
Monday, Oct 22
10:45 am
MO_5_2572 - Estimated Increase in Mean Lifetime Survival for Glioblastoma Patients Age 65 Years and Older Treated with Tumor Treating Fields and Temozolomide Compared to Patients Treated with Temozolomide Alone
Location: Innovation Hub, Exhibit Hall 3
Gregory Guzauskas, PhD
Monday, Oct 22
10:45 am
MO_5_2578 - A Novel Three Dimensional Conformal Radiation Therapy Technique to Decrease the Mean Parotid Gland Dose in Whole Brain Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Lara Hilal, MD
Monday, Oct 22
10:45 am
MO_5_2580 - Dose-Reduced Stereotactic Radiosurgery for Brain Metastases in the Era of CNS-Penetrating Systemic Therapies
Location: Innovation Hub, Exhibit Hall 3
Andrew Huang, MD
Monday, Oct 22
10:45 am
MO_5_2583 - Proton beam re-irradiation as salvage therapy for recurrent intracranial meningiomas
Location: Innovation Hub, Exhibit Hall 3
Brandon Imber, MD, MS
Monday, Oct 22
10:45 am
MO_5_2584 - Defining an Intermediate Risk Group for Low Grade Glioma. An Analysis of the National Cancer Database
Location: Innovation Hub, Exhibit Hall 3
Vikram Jairam, MD – Yale-New Haven Hospital
Monday, Oct 22
10:45 am
MO_5_2589 - Stereotactic radiosurgery for hemorrhagic brain metastases from malignant melanoma
Location: Innovation Hub, Exhibit Hall 3
Kristine Bauer-Nilsen, MD, BS
Monday, Oct 22
10:45 am
MO_5_2799 - Clinical Outcomes of Reirradiation in IDH-mutant Astrocytomas and 1p/19q Codeleted Oligodendrogliomas
Location: Innovation Hub, Exhibit Hall 3
Soumon Rudra, MD
Monday, Oct 22
10:45 am
MO_6_2597 - Outcomes for advanced melanoma with brain metastases treated with stereotactic radiosurgery (SRS) with and without anti-PD1/PDL1 therapy
Location: Innovation Hub, Exhibit Hall 3
Nima Harandi, MD
Monday, Oct 22
10:45 am
MO_6_2602 - Evolution in the Role of Stereotactic Radiosurgery in Patients with Multiple Brain Metastases: An International Survey
Location: Innovation Hub, Exhibit Hall 3
Sunil Dutta, MD
Monday, Oct 22
10:45 am
MO_6_2603 - Improved Outcomes With Adjuvant Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiation Therapy for Resected Intracranial Metastases
Location: Innovation Hub, Exhibit Hall 3
David Francis, MD
Monday, Oct 22
10:45 am
MO_6_2605 - Toxicity and Local Control Outcomes for Brain Metastases Managed with Resection and Aggressive Reirradiation after Initial Radiosurgery Failure
Location: Innovation Hub, Exhibit Hall 3
Brock Baker, MD
Monday, Oct 22
10:45 am
MO_6_2609 - Predictors for and Clinical Impact of Time between Surgical Resection and Radiation Therapy in Glioblastoma: Analysis of the National Cancer Database
Location: Innovation Hub, Exhibit Hall 3
Samantha Buszek, MD
Monday, Oct 22
10:45 am
MO_6_2616 - Treatment of Multiple Brain Metastases Using Single Isocentric Technique with Forward Planned Dynamic Arcs
Location: Innovation Hub, Exhibit Hall 3
Deborah Jiang, MD, MS
Monday, Oct 22
10:45 am
MO_6_2619 - Clinical Outcomes for Primary Parenchymal Tumor of Intermediate Differentiation
Location: Innovation Hub, Exhibit Hall 3
Behnood Khodayari, MD, MS – Kaiser Permanente Los Angeles Medical Center
Monday, Oct 22
10:45 am
MO_6_2621 - Initial clinical and advanced imaging outcomes from a multi-institutional phase I dose-escalation trial of RRx-001 plus whole brain radiation for patients with brain metastases
Location: Innovation Hub, Exhibit Hall 3
Michelle Kim, MD
Monday, Oct 22
10:45 am
MO_6_2622 - Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma
Location: Innovation Hub, Exhibit Hall 3
Nalee Kim, MD
Monday, Oct 22
10:45 am
MO_6_2623 - Single-Isocenter, Volumetric Modulated Arc Radiosurgery for Multiple Brain Metastases in a Single Session
Location: Innovation Hub, Exhibit Hall 3
Joshua Petit, MD
Monday, Oct 22
10:45 am
MO_7_2625 - Spine stereotactic radiosurgery offers excellent local control in patients with bulky spinal disease
Location: Innovation Hub, Exhibit Hall 3
Farasat Kazmi, MB, MS
Monday, Oct 22
10:45 am
MO_7_2629 - HER2 Status and Long Term Local Control Following SRS for Breast Cancer Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
Naren Ramakrishna, MD, PhD
Monday, Oct 22
10:45 am
MO_7_2630 - Safety profile of tumor treating fields in adult glioblastoma patients with implanted non-programmable shunts, programmable shunts, and pacemakers/defibrillators: 6-year updated retrospective analysis
Location: Innovation Hub, Exhibit Hall 3
Yvonne Kew, MD, PhD
Monday, Oct 22
10:45 am
MO_7_2631 - Stereotactic Radiosurgery with Concurrent HER2-directed Therapy is Associated with Improved Objective Response for Breast Cancer Brain Metastasis
Location: Innovation Hub, Exhibit Hall 3
Joseph Kim, BA – Case Western Reserve University School of Medicine
Monday, Oct 22
10:45 am
MO_7_2635 - Results of Hypofractionated Stereotactic Radiation Therapy (HSRT) for Large Brain Metastases and Resection Cavities
Location: Innovation Hub, Exhibit Hall 3
Naren Ramakrishna, MD, PhD
Monday, Oct 22
10:45 am
MO_7_2637 - Stereotactic Radiosurgery (SRS) for Vestibular Schwannoma: Longitudinal Audiologic Assessment in Single and Fractionated Treatments.
Location: Innovation Hub, Exhibit Hall 3
Mohamed Khattab, MD
Monday, Oct 22
10:45 am
MO_7_2638 - Time sequential changes of epithelial-mesenchymal transition signaling induced by ionizing radiation using next-generation sequencing in glioblastoma
Location: Innovation Hub, Exhibit Hall 3
Yi-Jun Kim, MD
Monday, Oct 22
10:45 am
MO_7_2640 - Improved Local Control with Internal Dose-Escalation for Melanoma Brain Metastases Treated with Stereotactic Radiosurgery
Location: Innovation Hub, Exhibit Hall 3
William Kennedy, MD
Monday, Oct 22
10:45 am
MO_7_2641 - Stereotactic Radiosurgery for Vestibular Schwannoma: Longitudinal Radiographic Outcomes Single and Fractionated Treatments.
Location: Innovation Hub, Exhibit Hall 3
Mohamed Khattab, MD
Monday, Oct 22
10:45 am
MO_7_2896 - Metalloproteinase inhibitor 4 to vascular endothelial growth factor A ratio is a prognostic factor of chemoradiation in glioblastoma
Location: Innovation Hub, Exhibit Hall 3
Weir Chiang You, MD, PhD
Monday, Oct 22
10:45 am
MO_8_2644 - The use of anti-PD1 therapy in melanoma patients with known brain metastases: Survival, durable intracranial progression free survival and radionecrosis
Location: Innovation Hub, Exhibit Hall 3
Rifaquat Rahman, MD, BA
Monday, Oct 22
10:45 am
MO_8_2645 - Adverse Radiation Effect and Disease Control in Patients Undergoing Concurrent Stereotactic Radiosurgery and Immunotherapy for Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
Julie Koenig, BS
Monday, Oct 22
10:45 am
MO_8_2651 - Edema or Margin in Glioblastoma CTV Impact on Pattern of Recurrence and Survival of Two Different CTV Delineations Independently Peer Reviewed.
Location: Innovation Hub, Exhibit Hall 3
Ciro Mazzarella, MD
Monday, Oct 22
10:45 am
MO_8_2662 - Oligodendroglioma Patients with 1p/19q Co-deletion Treated with Early or Delayed Radiation Therapy over the Last Two Decades: A Multi-institutional Report
Location: Innovation Hub, Exhibit Hall 3
Alexander Lin, MD, PhD
Monday, Oct 22
10:45 am
MO_8_2668 - Helical Tomotherapy for Whole- Brain Irradiation With Integrated Boost to Multiple Brain Metastases: Dosimetric Analysis and Clinical Outcomes
Location: Innovation Hub, Exhibit Hall 3
Yuchao Ma, MD
Monday, Oct 22
10:45 am
MO_8_2671 - Impact of Distance from Isocenter on Local Control when utilizing Single Isocenter Frameless VMAT SRS for Intact Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
Samuel Marcrom, MD – University of Alabama Birmingham
Monday, Oct 22
10:45 am
MO_8_2674 - Hippocampal avoidance in Whole Brain Radiation Therapy for Metastases - Comparative Neurocognitive and Dosimetric Assessment
Location: Innovation Hub, Exhibit Hall 3
Vibhay Pareek, DR
Monday, Oct 22
10:45 am
MO_8_2675 - Outcome analysis and impact of prognostic factors on survival of 111 Adult Medulloblastoma patients : A long term single institutional study.
Location: Innovation Hub, Exhibit Hall 3
Roshankumar Patil, MD, MBBS
Monday, Oct 22
10:45 am
MO_8_2676 - Concurrent Immunotherapy Usage and Asymmetric Growth May Distinguish True Progression from Treatment Effect in Growing Brain Metastases after Stereotactic Radiosurgery
Location: Innovation Hub, Exhibit Hall 3
Luke Peng, MD, MS
Monday, Oct 22
10:45 am
MO_8_2677 - Neurological death is common in patients with EGFR mutant non-small cell lung cancer
Location: Innovation Hub, Exhibit Hall 3
Matthew Ramotar, BS
Monday, Oct 22
10:45 am
MO_9_2681 - A Multicenter Prospective Cohort Study Evaluating Quality of Life after Radiation or Surgery for Potentially Unstable Spinal Metastases
Location: Innovation Hub, Exhibit Hall 3
Arjun Sahgal, MD – Sunnybrook Health Sciences Centre
Monday, Oct 22
10:45 am
MO_9_2683 - Potential Prognostic Markers for Survival and Neurologic Death in Patients with Breast Cancer Brain Metastases who receive upfront SRS Alone
Location: Innovation Hub, Exhibit Hall 3
Rachel Shenker, BS
Monday, Oct 22
10:45 am
MO_9_2684 - Dosimetric Comparison of Volumetric Modulated Arc Therapy Versus 3-Dimensional Conformal Radiation Therapy in Post-Operative Patients of High Grade Glioma
Location: Innovation Hub, Exhibit Hall 3
Harikesh Bahadur Singh, MD
Monday, Oct 22
10:45 am
MO_9_2690 - Outcomes Following Definitive Single Fraction Stereotactic Radiosurgery for Larger Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
Fabio Ynoe Moraes, MD
Monday, Oct 22
10:45 am
MO_9_2696 - A Contour-Based Approach for Predicting Corneal Toxicity in Patients with Uveal Melanoma Treated with Proton Therapy
Location: Innovation Hub, Exhibit Hall 3
Howard Lee, BA
Monday, Oct 22
10:45 am
MO_9_2698 - Survival Effect Difference of Whole-Brain Radiation Therapy and TKIs in Patients with Brain Metastases from Non-Small Cell Lung Cancer Stratified by EGFR Mutation Status
Location: Innovation Hub, Exhibit Hall 3
Zhensheng Li, MD, PhD
Monday, Oct 22
10:45 am
MO_9_2702 - The Effect of Debulking Surgery on Brainstem Dosimetry and Toxicity for Large Vestibular Schwannomas Treated with Fractionated Stereotactic Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Matthew Mallory, MD
Monday, Oct 22
10:45 am
MO_9_2703 - Correlation of Magnetic Resonance Imaging Apparent Diffusion Coeffecient Values with Treatment Outcome in High Grade Glioma Patients Undergoing Concurrent Chemoradiation
Location: Innovation Hub, Exhibit Hall 3
Vikram Manoor Maiya, MD
Monday, Oct 22
10:45 am
MO_9_2707 - Clinical, Dosimetric, and Radiographic Predictors of Local Failure Following Stereotactic Radiosurgery for Melanoma Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
Adrianna Masters, MD, PhD
Monday, Oct 22
10:45 am
MO_9_2736 - Survival and Prognostic Factors in Patients with Gastrointestinal Cancers and Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
William Breen, MD
Monday, Oct 22
10:45 am
MO_10_2709 - Nationwide Characteristics of Providers Utilizing Tumor Treating Fields for Newly Diagnosed Glioblastoma
Location: Innovation Hub, Exhibit Hall 3
Shearwood McClelland, MD
Monday, Oct 22
10:45 am
MO_10_2710 - Tumor Cavity Recurrence after Stereotactic Radiosurgery of Surgically Resected Brain Metastases: Implication of Deviations from Contouring Guidelines
Location: Innovation Hub, Exhibit Hall 3
David McDermott, MD
Monday, Oct 22
10:45 am
MO_10_2712 - Daily Tracking with MRI-Guided Radiation Therapy of Glioblastoma Resection Cavity and Cerebral Edema Volumes
Location: Innovation Hub, Exhibit Hall 3
Shahil Mehta, BS
Monday, Oct 22
10:45 am
MO_10_2714 - Radiation-induced edema after single or multi-fraction stereotactic radiosurgery (SRS) for non-base of skull (non-BOS) meningioma: A pooled analysis
Location: Innovation Hub, Exhibit Hall 3
Michael Milano, MD, PhD
Monday, Oct 22
10:45 am
MO_10_2715 - Early Objective Response as a Prognosticator for Final Objective Response and Survival following SRS for Brain Metastases Treated with Concurrent Systemic Therapy
Location: Innovation Hub, Exhibit Hall 3
Joseph Kim, BA – Case Western Reserve University School of Medicine
Monday, Oct 22
10:45 am
MO_10_2717 - Outcomes of uveal melanoma with distant metastasis at initial staging: Impact of primary tumor therapy
Location: Innovation Hub, Exhibit Hall 3
Leslie Modlin, MD
Monday, Oct 22
10:45 am
MO_10_2718 - Point-of-care local failure and overall survival prediction models for meningioma
Location: Innovation Hub, Exhibit Hall 3
Olivier Morin, PhD
Monday, Oct 22
10:45 am
MO_10_2721 - Patient Factors Predicting Intracranial Progression: Optimizing MRI Surveillance Interval Following Brain Metastases SRS
Location: Innovation Hub, Exhibit Hall 3
Brahma Natarajan, BS
Monday, Oct 22
10:45 am
MO_10_2722 - Risk Factors for Early Cognitive Deterioration after Whole-Brain Radiation Therapy for Brain Metastasis
Location: Innovation Hub, Exhibit Hall 3
Toshimichi Nakano, MD
Monday, Oct 22
10:45 am
MO_11_2691 - Pretreatment Texture Analysis of Routine Magnetic Resonance Images and Shape Analysis of the Diffusion Tensor predict Volumetric Response after Radiosurgery for Meningiomas
Location: Innovation Hub, Exhibit Hall 3
Herwin Speckter, MS
Monday, Oct 22
10:45 am
MO_11_2727 - Dosimetric Impact of Cesium 131 Seed Migration in Collagen Carrier Brain Brachytherapy Implants
Location: Innovation Hub, Exhibit Hall 3
Dilini Pinnaduwage, PhD
Monday, Oct 22
10:45 am
MO_11_2729 - Genomic Copy Number Gains of ErbB Family Members Predict Poor Clinical Outcomes in Glioma Patients
Location: Innovation Hub, Exhibit Hall 3
Liu Rui
Monday, Oct 22
10:45 am
MO_11_2730 - Timing and Sequence of Chemoradiation for Low-Grade Gliomas Meeting RTOG 9802 Criteria
Location: Innovation Hub, Exhibit Hall 3
Jeff Ryckman, MD, MSMP
Monday, Oct 22
10:45 am
MO_11_2735 - Efficacy and Safety of Hypofractionated Stereotactic Radiosurgery for Perioptic Lesions
Location: Innovation Hub, Exhibit Hall 3
Herwin Speckter, MS
Monday, Oct 22
10:45 am
MO_11_2737 - Treatment-Induced Increase in Eosinophil Count is Associated With Improved Overall Survival in Glioblastoma patients
Location: Innovation Hub, Exhibit Hall 3
Catherine Spina, MD, PhD
Monday, Oct 22
10:45 am
MO_11_2738 - Low dose Bevacizumab in treatment of radiation necrosis post IGRT with Cyberknife boost with Temozolamide for Glioma patients
Location: Innovation Hub, Exhibit Hall 3
Papaiah Susheela Sridhar, MD
Monday, Oct 22
10:45 am
MO_11_2741 - Modern Re-irradiation Versus Post-Bevacizumab Salvage Chemotherapy in Treating Recurrent High-Grade Gliomas
Location: Innovation Hub, Exhibit Hall 3
John Lee, BS
Monday, Oct 22
10:45 am
MO_11_2745 - Radiation-induced vascular malformations mimicking tumor in MRI-based treatment response assessment maps (TRAMs)
Location: Innovation Hub, Exhibit Hall 3
Yael Mardor, PhD
Monday, Oct 22
10:45 am
MO_11_2746 - Spine stereotactic radiosurgery in the treatment of metastatic pheochromocytoma: an updated case series
Location: Innovation Hub, Exhibit Hall 3
Shane Mesko, MD, MBA
Monday, Oct 22
10:45 am
MO_12_2760 - Do Tumor PD-L1 Expression and Neutrophil to Lymphocyte Ratio Influence the Efficacy of Stereotactic Radiosurgery for Brain Metastases from Non-Small Cell Lung Cancer?
Location: Innovation Hub, Exhibit Hall 3
Abimbola Orisamolu, MD
Monday, Oct 22
10:45 am
MO_12_2761 - Clinical Outcome of Brainstem Glioma Treated With or Without Concurrent Chemoradiotherapy: An Institutional Retrospective Analysis of 71 Patients
Location: Innovation Hub, Exhibit Hall 3
Goura Rath, MD
Monday, Oct 22
10:45 am
MO_12_2764 - Outcomes following Stereotactic Radiation (SRS/SRT) plus Surgery versus SRS/SRT Alone for Single or Solitary Metastasis in Patients with Controlled Systemic Disease: A Single-Institution Study
Location: Innovation Hub, Exhibit Hall 3
Nayan Lamba, BA
Monday, Oct 22
10:45 am
MO_12_2766 - Radiosurgery outcome related to chemotherapy association in relapsed glioblastoma multiforme.
Location: Innovation Hub, Exhibit Hall 3
Luis Larrea, MD, PhD
Monday, Oct 22
10:45 am
MO_12_2767 - The Role of High B-Value Diffusion MRI in the Molecular Classification of Lower Grade Gliomas
Location: Innovation Hub, Exhibit Hall 3
Anna Laucis, MD, MPhil
Monday, Oct 22
10:45 am
MO_12_2768 - Impact of Diabetes Mellitus and Metformin on Clinical Outcomes of Brain Metastasis Patients Treated With Stereotactic Radiosurgery
Location: Innovation Hub, Exhibit Hall 3
Michael LeCompte, MS
Monday, Oct 22
10:45 am
MO_12_2778 - Stereotactic Body Radiation Therapy is an Effective and Safe Treatment for Benign Spinal Tumors
Location: Innovation Hub, Exhibit Hall 3
Shane Lloyd, MD, PhD
Monday, Oct 22
10:45 am
MO_12_2781 - Role of Hypofractionated Radiation Therapy in a Multidisiplinary Approach to Treat Persistent Cushing's Disease
Location: Innovation Hub, Exhibit Hall 3
Rasim Meral, MD, PhD
Monday, Oct 22
10:45 am
MO_12_2786 - Comparison of Local Failure and Radionecrosis According to Dose Prescription for Small to Medium Sized Brain Metastasis treated with Radiosurgery
Location: Innovation Hub, Exhibit Hall 3
Fabio Ynoe Moraes, MD
Monday, Oct 22
10:45 am
MO_12_2787 - Local failure and radionecrosis following single fraction stereotactic radiosurgery for surgical cavities from brain metastases
Location: Innovation Hub, Exhibit Hall 3
Fabio Ynoe Moraes, MD
Monday, Oct 22
10:45 am
MO_13_2506 - Radiation-induced White Matter Injury Following Radiation Therapy in Glioblastoma patients
Location: Innovation Hub, Exhibit Hall 3
Hesham Elhalawani, MD, MS
Monday, Oct 22
10:45 am
MO_13_2563 - Investigating Semi-Quantitative in-Vivo Spatial and Dosimetric Analytical Algorithms to Report GBM Patterns of Failures Following Chemoradiation in the IMRT Era
Location: Innovation Hub, Exhibit Hall 3
Hesham Elhalawani, MD, MS
Monday, Oct 22
10:45 am
MO_13_2792 - Effect of Whole Brain Radiation Therapy on the Absolute Brain Volume Loss
Location: Innovation Hub, Exhibit Hall 3
Lindsy Pang, BS
Monday, Oct 22
10:45 am
MO_13_2794 - Report of Neurotoxicity after Concurrent Whole Brain Radiation Therapy and Checkpoint Blockade Immunotherapy for Patients with Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
Robert Press, MD
Monday, Oct 22
10:45 am
MO_13_2800 - Examining Computerized Neurocognitive Screening Test in Predicting Cerebral Progression Free Survival in Patients Undergoing Brain Stereotactic Radiation Therapy for Brain Metastases: A Pilot Study
Location: Innovation Hub, Exhibit Hall 3
Emmanuelle Reygagne
Monday, Oct 22
10:45 am
MO_13_2801 - Effectiveness of Repeat Courses of Stereotactic Radiosurgery in Patients with Brain Metastases: A Single Institution Experience
Location: Innovation Hub, Exhibit Hall 3
Anurag Saraf, MD
Monday, Oct 22
10:45 am
MO_13_2804 - Investigating nationwide usage trends and relative efficacy of combined modality treatments for elderly glioblastoma patients
Location: Innovation Hub, Exhibit Hall 3
Deborah Smith, BS
Monday, Oct 22
10:45 am
MO_13_2805 - Evaluating Nationwide Practice Patterns in Chemoradiotherapeutic Regimens and Relative Efficacy of Chemoradiation Versus Adjuvant Radiation for Grade III Gliomas
Location: Innovation Hub, Exhibit Hall 3
Deborah Smith, BS
Monday, Oct 22
10:45 am
MO_13_2806 - Severe lymphopenia after chemoradiation treatment is associated with worse survival in patients with newly diagnosed GBM
Location: Innovation Hub, Exhibit Hall 3
Andrew Song, MD
Monday, Oct 22
10:45 am
MO_14_2807 - Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing
Location: Innovation Hub, Exhibit Hall 3
Rupesh Kotecha, MD
Monday, Oct 22
10:45 am
MO_14_2809 - Is Risk Group-Adapted Adjuvant Radiation Therapy Beneficial for WHO Grade I/II Skull Base Meningioma? a Propensity Score-Matched Analysis
Location: Innovation Hub, Exhibit Hall 3
Sangjoon Park, MD – Yonsei University Health System
Monday, Oct 22
10:45 am
MO_14_2812 - Single Fraction and Fractionated Radiosurgery for Treatment of Brainstem Metastases
Location: Innovation Hub, Exhibit Hall 3
Paul Koffer, MD
Monday, Oct 22
10:45 am
MO_14_2813 - Automatic Contour Propagation of Organs-at-Risk on Serial MRIs and Dosimetric Implications in Glioblastoma Patients Undergoing Chemo-Radiation
Location: Innovation Hub, Exhibit Hall 3
Sangjune Lee, MD, MS, BS
Monday, Oct 22
10:45 am
MO_14_2814 - Whole-Brain Radiation Therapy Plus Sequential or Simultaneous Integrated Boost for the Treatment of Finite Number of Brain Metastases in Non-Small Cell Lung Cancer
Location: Innovation Hub, Exhibit Hall 3
Dai Yuan Ma, MD
Monday, Oct 22
10:45 am
MO_14_2817 - Initial Response Lag time in Flat versus Non-Flat beam frameless Image Guided Trigeminal Radiosurgery
Location: Innovation Hub, Exhibit Hall 3
Vangipuram Shankar, MD
Monday, Oct 22
10:45 am
MO_14_2818 - Consensus Radiation Therapy Contouring Guidelines for Glioblastoma, Based on NRG Recommendations
Location: Innovation Hub, Exhibit Hall 3
Tim Kruser, MD – Northwestern Memorial Hospital
Monday, Oct 22
10:45 am
MO_14_2819 - Comparative Utilization Analysis of Radiation Modalities Among Adults with Primary Brain Tumors in the United States from 2004 to 2015
Location: Innovation Hub, Exhibit Hall 3
Ed Marchan, MD
Monday, Oct 22
10:45 am
MO_14_2820 - Improved Overall and Cause-Specific Survival for Melanoma Brain metastasis Patients Treated with Stereotactic Radiosurgery and Immunotherapy
Location: Innovation Hub, Exhibit Hall 3
Steven Nguyen, MD, BS
Monday, Oct 22
10:45 am
MO_14_2823 - SBRT for spine lesions: A novel optimized delivery technique
Location: Innovation Hub, Exhibit Hall 3
Daniel Saenz, PhD
Monday, Oct 22
10:45 am
MO_15_2827 - Endocrine Remission after Pituitary Stereotactic Radiosurgery:Differences in Rates of Response for Matched Cohorts of Cushing's Disease and Acromegaly Patients
Location: Innovation Hub, Exhibit Hall 3
Sunil Dutta, MD
Monday, Oct 22
10:45 am
MO_15_2834 - Cognitive-Linguistic Deficits Following Treatment of Brain Tumors: Results of a Prospective Pilot Study
Location: Innovation Hub, Exhibit Hall 3
Brianna Tranby, MA
Monday, Oct 22
10:45 am
MO_15_2839 - Similar local control rates for patients with meningiomas treated with proton therapy vs. IMRT
Location: Innovation Hub, Exhibit Hall 3
Kevin Tran, BS
Monday, Oct 22
10:45 am
MO_15_2846 - Safety and Efficacy of Proton Beam Therapy for High-Grade Glioma: Initial Report From the Proton Collaborative Group(PCG)
Location: Innovation Hub, Exhibit Hall 3
Sujay Vora, MD
Monday, Oct 22
10:45 am
MO_15_2847 - Long-term Outcomes and Imaging Response for Image-Guided Stereotactic Radiosurgery (IG-SRS) of Brain Arteriovenous Malformations (AVM)
Location: Innovation Hub, Exhibit Hall 3
Jacob Trotter, BS
Monday, Oct 22
10:45 am
MO_15_2848 - Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability
Location: Innovation Hub, Exhibit Hall 3
Brandon Turner, MS
Monday, Oct 22
10:45 am
MO_15_2850 - Assessing the Association between Tumor Location and Toxicity Outcomes after Stereotactic Radiosurgery for Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
Boya Wang, BS
Monday, Oct 22
10:45 am
MO_15_2852 - Radiation Dose Escalation for Localized Ependymoma
Location: Innovation Hub, Exhibit Hall 3
Jennifer Vogel, MD – University of Pennsylvania
Monday, Oct 22
10:45 am
MO_15_2854 - Feasibility of Hippocampal Dose-volume Parameters Associated with Memory Decline in Volumetric Modulated Arc Therapy for Supratentorial Tumors
Location: Innovation Hub, Exhibit Hall 3
Shigeo Takahashi, MD, PhD
Monday, Oct 22
10:45 am
MO_15_2857 - Quantitative MR measurements of mean diffusivity in glioblastoma patients with Tumor Treating Fields plus standard therapy versus standard treatment alone
Location: Innovation Hub, Exhibit Hall 3
Josef Vymazal, MD, DSc
Monday, Oct 22
10:45 am
MO_16_2864 - Safety of TTFields applied to the torso: Meta-analysis of 176 patients from four phase I-II trials
Location: Innovation Hub, Exhibit Hall 3
Ignance Vergote
Monday, Oct 22
10:45 am
MO_16_2868 - Stereotactic Body Radiation Therapy (SBRT) for Spinal Metastases at the Extremes of the Spine: Imaging-Based Outcomes for Cervical and Sacral Metastases
Location: Innovation Hub, Exhibit Hall 3
K. Liang Zeng, MD
Monday, Oct 22
10:45 am
MO_16_2869 - A Pilot/Phase II Study of Stereotactic Radiosurgery for Brain Metastases Using Rational Dose Selection
Location: Innovation Hub, Exhibit Hall 3
James Yu, MD, MHS – Yale University
Monday, Oct 22
10:45 am
MO_16_2875 - Feasibility of a Risk-Adapted Approach to Whole Brain Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Ted Yanagihara, MD, PhD
Monday, Oct 22
10:45 am
MO_16_2878 - Cancer Genetic Markers According to Radiotherapeutic Response in Patients with Glioblastoma - Radiogenomic Approach for Precision Medicine
Location: Innovation Hub, Exhibit Hall 3
Kyungmi Yang, MD
Monday, Oct 22
10:45 am
MO_16_2879 - Treatment of complex brain metastases with helical Tomotherapy: Results of a phase II trial
Location: Innovation Hub, Exhibit Hall 3
Siran Yang, MD
Monday, Oct 22
10:45 am
MO_16_2884 - Stereotactic Radiosurgery as a Component of Treatment for Brain Metastases in Small Cell Lung Cancer Patients
Location: Innovation Hub, Exhibit Hall 3
Justin Yuan, BS
Monday, Oct 22
10:45 am
MO_16_2890 - Outcomes of whole brain radiation with simultaneous in-field boost (SIB) for the treatment of brain metastases
Location: Innovation Hub, Exhibit Hall 3
Jim Zhong, MD
Monday, Oct 22
10:45 am
MO_16_2894 - Propensity-Matched Analysis of Prognosis Following Whole Brain Radiation Therapy Alone Versus Whole Brain Radiation Therapy Combined with Local Boost in Small Cell Lung Cancer Patients With Brain Metastases
Location: Innovation Hub, Exhibit Hall 3
Qingyang Zhuang, BS
Monday, Oct 22
10:45 am
MO_16_2895 - Spine Stereotactic Body Radiation Therapy with Concurrent Systemic Therapies for Treatment of Metastatic Breast Cancer
Location: Innovation Hub, Exhibit Hall 3
Rachel Zhuang, BS
Monday, Oct 22
10:45 am
92 - Elevated MGMT Gene Expression Is Independently Associated With Worse Overall Survival in NRG Oncology/RTOG 9813: A Phase III Study of Radiation Therapy (RT) and Temozolomide (TMZ) Versus RT and Nitrosourea (NU) in Anaplastic Grade III Glioma
Location: Room 004
Jessica Fleming, PhD
Monday, Oct 22
10:45 am
SS 13 - CNS 2 - Gliomas
Location: Room 004
Raju Raval, MD, DPhil
Monday, Oct 22
10:55 am
93 - MGMT Protein Expression Adds Prognostic Value Beyond MGMT Promoter Methylation and Stratifies Survival Prognoses of Un-Methylated Glioblastoma Patients
Location: Room 004
Aline Becker, MD, PhD
Monday, Oct 22
11:05 am
94 - Development and Validation of Xenograft-Based Platform-Independent Gene Signatures That Predict Response to Alkylating Chemotherapy, Radiation, and Combination Therapy in Glioblastoma.
Location: Room 004
Shuang Zhao, MD, MSE
Monday, Oct 22
11:15 am
95 - Analysis of RTOG-RPA Scores in the Phase 3 EF-14 Trial of Tumor Treating Fields With Temozolomide (TTFields/TMZ) Versus TMZ Alone in Newly Diagnosed Glioblastoma.
Location: Room 004
Kevin Choe, MD, PhD
Monday, Oct 22
11:25 am
Scientific Discussant
Location: Room 004
Kevin Camphausen, MD
Monday, Oct 22
11:35 am
96 - A Phase 2 Trial of Neoadjuvant Temozolomide (TMZ) Followed By Accelerated Hypofractionated Radiation Therapy (AHRT) and TMZ Followed By Adjuvant TMZ in Patients with Newly Diagnosed Glioblastoma (GBM): Long Term Survival and Toxicity Analysis
Location: Room 004
George Shenouda, MD, PhD
Monday, Oct 22
11:45 am
97 - A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients With Glioblastoma: Integrative Analyses of Transcriptome and Methylome
Location: Room 004
Bum Sup Jang, MD
Monday, Oct 22
11:55 am
98 - Risk Factors for Progression of Low Grade Glioma Following Gross Total Resection and Observation in the Molecular Era
Location: Room 004
Vamsi Varra, BS
Monday, Oct 22
12:05 pm
Scientific Discussant
Location: Room 004
Ranjit Bindra, MD, PhD – Yale University
Monday, Oct 22
4:15 pm
Presentation 1
Location: Room 303
Kristin Redmond, MD, MPH – Johns Hopkins University
Monday, Oct 22
4:15 pm
eContouring for CNS/SBRT Spine
Location: Room 303
Stephanie Terezakis, MD – Johns Hopkins School of Medicine
Monday, Oct 22
4:15 pm
eContouring for CNS/SBRT Spine
Location: Room 303
Karyn Goodman, MD, MS – University of Colorado Cancer Center
Monday, Oct 22
4:15 pm
eContouring 08 (Live SA-CME) - eContouring for CNS/SBRT Spine
Location: Room 303
Monday, Oct 22
4:35 pm
Presentation 2
Location: Room 303
Simon Lo, MB, ChB, FACR, FASTRO – University of Washington
Tuesday, Oct 23
1:00 pm
Case: Surgical Management of Gliomas
Location: Room 008
Albert Kim, MD, PhD
Tuesday, Oct 23
1:00 pm
EDU 24 - (INTERACTIVE) Challenging Cases in the Management of Gliomas
Location: Room 008
Christina Irene Tsien, MD – Washington University, St. Louis
Tuesday, Oct 23
1:20 pm
Update on Brain Tumor Imaging in the Molecular Era
Location: Room 008
Soonmee Cha, MD
Tuesday, Oct 23
1:40 pm
Case: Management of Primary and Recurrent GBM
Location: Room 008
Roger Stupp, MD
Tuesday, Oct 23
2:00 pm
Case: Management of Low Grade and Anaplastic Gliomas
Location: Room 008
Christina Irene Tsien, MD – Washington University, St. Louis
Tuesday, Oct 23
2:20 pm
Audience Q&A
Location: Room 008
Christina Irene Tsien, MD – Washington University, St. Louis
Tuesday, Oct 23
4:45 pm
Indications and contraindications for single and fractionated SRS for benign brain tumors
Location: Room 007 C/D
Joshua Silverman, MD, PhD – New York University Cancer Center
Tuesday, Oct 23
4:45 pm
Panel 13 - (INTERACTIVE) Practical Case Based Discussions of Single vs Fractionated Stereotactic Radiosurgery for Benign Brain Tumors
Location: Room 007 C/D
Tony Wang, MD – Columbia University Medical Center
Tuesday, Oct 23
5:05 pm
Surgical management of benign brain tumors in the era of molecular classification
Location: Room 007 C/D
Albert Kim, MD, PhD
Tuesday, Oct 23
5:25 pm
Advances in neuroimaging for benign brain tumors
Location: Room 007 C/D
Jason Johnson, MD
Tuesday, Oct 23
5:45 pm
Contouring and treatment planning - dos and dont's
Location: Room 007 C/D
Tony Wang, MD – Columbia University Medical Center
Tuesday, Oct 23
6:05 pm
Audience Q&A
Location: Room 007 C/D
Tony Wang, MD – Columbia University Medical Center
Wednesday, Oct 24
7:45 am
Introduction to spine SBRT including evaluating candidacy and target/normal tissue delineation
Location: Room 303
Kristin Redmond, MD, MPH – Johns Hopkins University
Wednesday, Oct 24
7:45 am
EDU 33 - (INTERACTIVE) Stereotactic Body Radiation Therapy for Spine Metastases: What Can Be Offered When Conventional Radiation Fails?
Location: Room 303
Kristin Redmond, MD, MPH – Johns Hopkins University
Wednesday, Oct 24
8:03 am
Local control and toxicity of spine SBRT
Location: Room 303
Scott Soltys, MD – Stanford Department of Radiation Oncology
Wednesday, Oct 24
8:21 am
Re-irradiation of spinal metastases with a focus on normal tissue tolerance in the re-irradiation setting
Location: Room 303
Amol Ghia, MD
Wednesday, Oct 24
8:39 am
Management options when radiation therapy fails
Location: Room 303
Mark Bilsky, MD
Wednesday, Oct 24
8:57 am
Audience Q&A
Location: Room 303
Kristin Redmond, MD, MPH – Johns Hopkins University
Wednesday, Oct 24
1:30 pm
289 - Treatment of Brain Metastases With Stereotactic Radiosurgery and Immune Checkpoint Inhibitors: An International Meta-Analysis of Individual Patient Data
Location: Room 004
Eric Lehrer, MD, MS
Wednesday, Oct 24
1:30 pm
SS 40 - CNS 3 - CNS Metastasis
Location: Room 004
Stuart Burri, MD; Kevin Chua, MBBS
Wednesday, Oct 24
1:40 pm
290 - Improved Survival Following Immunotherapy in Patients With Lung and Melanoma Primaries Metastatic to the Brain Treated With Upfront Stereotactic Radiosurgery
Location: Room 004
Claire Lanier, BS
Wednesday, Oct 24
1:50 pm
291 - Preoperative Radiosurgery For Resected Brain Metastases: Updated Analysis of Efficacy and Toxicity Of A Novel Treatment Paradigm
Location: Room 004
Roshan Prabhu, MD, MS
Wednesday, Oct 24
2:00 pm
292 - Initial SRS for Patients With 5-15 Brain Metastases: Results of a Multi-Institutional Experience
Location: Room 004
Ryan Hughes, MD – Wake Forest Baptist Medical Center
Wednesday, Oct 24
2:10 pm
293 - A Phase II Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases
Location: Room 004
Kristin Redmond, MD, MPH – Johns Hopkins University
Wednesday, Oct 24
2:20 pm
294 - Patterns of Failure and Outcomes Based On Management of Leptomeningeal Disease After Surgical Resection and Radiosurgery for Brain Metastases: A Multi-Institutional Analysis
Location: Room 004
Roshan Prabhu, MD, MS
Wednesday, Oct 24
2:30 pm
295 - Randomized Phase III Trial Comparing Gamma Knife and Linac Based (EDGE) Approaches for Brain Metastases Radiosurgery: Results from the Gadget Trial
Location: Room 004
Pierina Navarria, MD
Wednesday, Oct 24
2:40 pm
296 - Salvage Stereotactic Radiosurgery is Associated With Improved Overall Survival Compared to Whole Brain Radiation in the Setting of Progressive Brain Metastases
Location: Room 004
Michael Soike, MD – Wake Forest University Medical Center
Wednesday, Oct 24
2:50 pm
Scientific Discussant
Location: Room 004
Ayal Aizer, MD
Wednesday, Oct 24
3:15 pm
Radiosurgery versus Neurosurgery (or both?): the evidence
Location: Room 006
Stephanie Weiss, MD, FASTRO – Fox Chase Cancer Center
Wednesday, Oct 24
3:15 pm
Panel 23 (Live SA-CME) - An Evidence-Driven Guide to Thinking Through Radiation and Surgery for Brain Metastasis
Location: Room 006
Lawrence Kleinberg, MD; Stephen Shiao, MD, PhD
Wednesday, Oct 24
3:35 pm
Post operative SRS
Location: Room 006
Kathryn Beal, MD – Memorial Sloan Kettering Cancer Center
Wednesday, Oct 24
3:55 pm
Technique for post-operative treatment planning
Location: Room 006
Scott Soltys, MD – Stanford Department of Radiation Oncology
Wednesday, Oct 24
4:15 pm
Preoperative Radiosurgery
Location: Room 006
Erin Murphy, MD
Sunday, Oct 21
9:45 am
Updates In The Management of Brain Metastases
Location: Room 304
Simon Lo, MB, ChB, FACR, FASTRO – University of Washington
Sunday, Oct 21
9:45 am
PRO 07 - PRO - Central Nervous System
Location: Room 304
Christina Irene Tsien, MD – Washington University, St. Louis
Sunday, Oct 21
10:05 am
Recent Advances In The Evaluation and Management Of Gliomas (both low grade and high grade)
Location: Room 304
Christina Irene Tsien, MD – Washington University, St. Louis
Sunday, Oct 21
10:45 am
Meet the Expert - Central Nervous System
Location: ASTRO Connect: CNS #2245
Yoshiya Yamada, MD, FRCPC – Memorial Sloan Kettering Cancer Center
Sunday, Oct 21
10:45 am
MTE 13 - Meet The Expert Yoshiya Yamada, MD, FRCPC - CNS - Sunday
Sunday, Oct 21
1:45 pm
Meet the Expert - Central Nervous System
Location: ASTRO Connect: CNS #2245
Joshua Silverman, MD, PhD – New York University Cancer Center
Sunday, Oct 21
1:45 pm
MTE 18 - Meet The Expert Joshua S. Silverman, MD, PhD - CNS - Sunday
Sunday, Oct 21
4:15 pm
Meet the Expert - Central Nervous System
Location: ASTRO Connect: CNS #2245
Eric Chang, MD, FASTRO – Keck School of Medicine of USC
Sunday, Oct 21
4:15 pm
MTE 23 - Meet The Expert Eric Chang, MD, FASTRO - CNS - Sunday
Monday, Oct 22
11:15 am
Meet the Expert - Central Nervous System
Location: ASTRO Connect: CNS #2245
Stephanie Weiss, MD, FASTRO – Fox Chase Cancer Center
Monday, Oct 22
11:15 am
MTE 28 - Meet The Expert Stephanie Weiss, MD, FASTRO - CNS - Monday
Monday, Oct 22
4:15 pm
Meet the Expert - Central Nervous System
Location: ASTRO Connect: CNS #2245
Lia Halasz, MD – University of Washington
Monday, Oct 22
4:15 pm
MTE 33 - Meet The Expert Lia M. Halasz, MD - CNS - Monday
Tuesday, Oct 23
10:45 am
Meet the Expert - Central Nervous System
Location: ASTRO Connect: CNS #2245
Vinai Gondi, MD – Northwestern Medicine Cancer Center Warrenville
Tuesday, Oct 23
10:45 am
MTE 38 - Meet The Experts Vinai Gondi, MD and Minesh Mehta, MD, ChB, FASTRO - CNS - Tuesday
Tuesday, Oct 23
1:30 pm
Meet the Expert - Central Nervous System
Location: ASTRO Connect: CNS #2245
Tony Wang, MD – Columbia University Medical Center
Tuesday, Oct 23
1:30 pm
MTE 43 - Meet The Expert Tony Wang, MD - CNS - Tuesday
Tuesday, Oct 23
3:15 pm
Meet the Expert - Central Nervous System
Location: ASTRO Connect: CNS #2245
Kristin Redmond, MD, MPH – Johns Hopkins University
Tuesday, Oct 23
3:15 pm
MTE 48 - Meet The Expert Kristin Redmond, MD, MPH - CNS - Tuesday
Tuesday, Oct 23
4:15 pm
Meet the Expert - Central Nervous System
Location: ASTRO Connect: CNS #2245
Christina Irene Tsien, MD – Washington University, St. Louis
Tuesday, Oct 23
4:15 pm
MTE 53 - Meet The Expert Christina Irene Tsien, MD - CNS - Tuesday
Gastrointestinal Cancer
Sunday, Oct 21
10:30 am
eContouring for Prostate Cancer
Location: Room 303
Manisha Palta, MD – Duke Cancer Institute
Sunday, Oct 21
10:30 am
eContouring for Gastrointestinal Cancer
Location: Room 303
Stephanie Terezakis, MD – Johns Hopkins School of Medicine
Sunday, Oct 21
10:30 am
eContouring for Gastrointestinal Cancer
Location: Room 303
Karyn Goodman, MD, MS – University of Colorado Cancer Center
Sunday, Oct 21
10:30 am
eContouring 04 - eContouring for Gastrointestinal Cancer
Location: Room 303
Sunday, Oct 21
10:50 am
eContouring for Prostate Cancer
Location: Room 303
Salma Jabbour, MD – Rutgers Cancer Institute of New Jersey
Sunday, Oct 21
1:15 pm
Global overview of HyTEC
Location: Room 301
Lawrence Marks, MD, FASTRO
Sunday, Oct 21
1:15 pm
Panel 01 - (INTERACTIVE) HyTEC Report: SBRT/SABR in Abdominal Regions
Location: Room 301
Jimm Grimm, PhD; Ellen Yorke, PhD, FASTRO
Sunday, Oct 21
1:32 pm
Normal tissue dose-volume effects for SBRT-induced liver and gastrointestinal toxicities
Location: Room 301
Moyed Miften, PhD
Sunday, Oct 21
1:49 pm
Tumor control of primary and metastatic liver malignancies with SBRT
Location: Room 301
Nitin Ohri, MD, MS – Albert Einstein College of Medicine
Sunday, Oct 21
2:06 pm
SBRT and multidisciplinary advances for pancreatic cancer
Location: Room 301
Joseph Herman, MD, MS – MD Anderson Cancer Center
Sunday, Oct 21
2:30 pm
Concluding remarks on HyTEC dose-response modeling and reporting standards
Location: Room 301
Andrew Jackson, PhD
Sunday, Oct 21
2:40 pm
Audience Q&A
Location: Room 301
Jimm Grimm, PhD
Sunday, Oct 21
1:15 pm
SU_1_2000 - Correlation Between Immune Status After Neoadjuvant Therapy and Complete Response Rate in Patients with Locally Advanced Rectal Adenocarcinoma
Location: Innovation Hub, Exhibit Hall 3
Namita Agrawal, MD, BS
Sunday, Oct 21
1:15 pm
SU_1_2001 - Delta Radiomics Analysis for Hybrid MR-RT Imaging in Rectal Cancer for Response Prediction: A Hypothesis Generating Study
Location: Innovation Hub, Exhibit Hall 3
Nicola Dinapoli, MD, PhD
Sunday, Oct 21
1:15 pm
SU_1_2002 - Three-Dimensional Printing of Adaptive Bolus for Squamous Cell Carcinoma of the Anus
Location: Innovation Hub, Exhibit Hall 3
Michael Cardenas, MD
Sunday, Oct 21
1:15 pm
SU_1_2003 - Prospective Clinical Study of Capecitabine plus Oxaliplatin Concurrent Chemoradiotherapy after Radical Resection of Rectal Cancer
Location: Innovation Hub, Exhibit Hall 3
Wang Chen
Sunday, Oct 21
1:15 pm
SU_1_2004 - Stereotactic Body Radiation Therapy for Metastatic Colorectal Cancer: Comprehensive Review from a Large Academic Institution
Location: Innovation Hub, Exhibit Hall 3
Robert Thompson, MD
Sunday, Oct 21
1:15 pm
SU_1_2005 - Importance of Tumor Regression Grade in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy
Location: Innovation Hub, Exhibit Hall 3
Changhoon Song, MD, PhD
Sunday, Oct 21
1:15 pm
SU_1_2006 - Clinical Outcomes of Rectal Squamous Cell Carcinomas Treated With Chemoradiotherapy With or Without Surgery: A Rare Cancer Network Study.
Location: Innovation Hub, Exhibit Hall 3
Berardino De Bari
Sunday, Oct 21
1:15 pm
SU_1_2007 - Prognostic implications of altering the nodal staging for anal cancer in the American Joint Committee on Cancer 8
th
(AJCC8) Edition Staging Manual
Location: Innovation Hub, Exhibit Hall 3
Joshua Elson, MD, MPH
Sunday, Oct 21
1:15 pm
SU_1_2008 - The Utility of Positron Emission Tomography (PET) To Guide Radiation Therapy Target Volume Determination As Compared With Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) for Rectal Cancer
Location: Innovation Hub, Exhibit Hall 3
Robert Fain, MD
Sunday, Oct 21
1:15 pm
SU_1_2009 - Overcoming the Barriers to the Use of Short Course Radiation Therapy in Locally Advanced Rectal Cancer: A Phase 1 Study of Short Course Radiation Therapy Concurrent with 5-Fluorouracil
Location: Innovation Hub, Exhibit Hall 3
Emma Fields, MD – Virginia Commonwealth University
Sunday, Oct 21
1:15 pm
SU_2_2010 - Immune Inflammation Indicators Predict Outcome in Anal Cancer Patients Undergoing Concurrent Chemo-radiation
Location: Innovation Hub, Exhibit Hall 3
Pierfrancesco Franco, MD, PhD
Sunday, Oct 21
1:15 pm
SU_2_2011 - Patterns of Inguinal Lymph Node Metastases in Anal Cancer: Recommendations for Elective Clinical Target Volume (CTV) Delineation
Location: Innovation Hub, Exhibit Hall 3
Allison Garda, MD
Sunday, Oct 21
1:15 pm
SU_2_2012 - Long-Term Survival and Local Control Outcomes in Oligometastatic Colorectal Cancer Treated with Liver Stereotactic Body Radiation Therapy Long-Term Survival and Local Control Outcomes in Oligometastatic Colorectal Cancer
Location: Innovation Hub, Exhibit Hall 3
Jason Hinton, MD, PharmD
Sunday, Oct 21
1:15 pm
SU_2_2013 - Intensity-modulated proton therapy (IMPT) reduces dose to pelvic bone marrow and normal pelvic organs when compared to volumetric-modulated arc therapy (VMAT) for patients with anal cancer
Location: Innovation Hub, Exhibit Hall 3
Emma Holliday
Sunday, Oct 21
1:15 pm
SU_2_2014 - The Efficacy and Tolerability of S-1 in the Treatment of Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer.
Location: Innovation Hub, Exhibit Hall 3
Nobuki Imano, MD
Sunday, Oct 21
1:15 pm
SU_2_2015 - Metastasis-Directed Stereotactic Body Radiation Therapy for Oligometastatic Colorectal Cancer: a Single Institution Experience
Location: Innovation Hub, Exhibit Hall 3
Krishan Jethwa, MD – Mayo Clinic
Sunday, Oct 21
1:15 pm
SU_2_2017 - Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma
Location: Innovation Hub, Exhibit Hall 3
Ami Kavi, MD
Sunday, Oct 21
1:15 pm
SU_2_2018 - The Impact of Hemoglobin on Outcomes in Anal Canal Cancer Treated with Definitive Chemoradiation
Location: Innovation Hub, Exhibit Hall 3
Sara Kelm, BS
Sunday, Oct 21
1:15 pm
SU_2_2019 - Short-course hyperfractionated accelerated radiation therapy (SC-HART) for rectal cancer stage UICC II - III (8
th
edition). Results from a single Austrian Institution
Location: Innovation Hub, Exhibit Hall 3
Lukas Kocik, MD
Sunday, Oct 21
1:15 pm
SU_2_2020 - Radical Therapeutic Strategies for Primary Unresectable Rectal Cancer- Radiochemotherapy, Conventional Radiation Therapy, and Hyperfractionated Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Malgorzata Kraszkiewicz, MD
Sunday, Oct 21
1:15 pm
SU_3_2021 - Nuclear Export Inhibition for Radiosensitization; a Proof-Of-Concept Phase I Clinical Trial of Neoadjuvant KPT-330 (Selinexor) Plus Chemoradiation in Locally Advanced Rectal Cancer
Location: Innovation Hub, Exhibit Hall 3
Yaacov Lawrence, MD, MRCP
Sunday, Oct 21
1:15 pm
SU_3_2022 - Survival Outcomes and Patterns of Management for Anal Adenocarcinoma: An Analysis of the National Cancer Data Base
Location: Innovation Hub, Exhibit Hall 3
Gary Lewis, MD
Sunday, Oct 21
1:15 pm
SU_3_2023 - Multiple Primary Malignancies in Patients with Anal Squamous Cell Carcinoma
Location: Innovation Hub, Exhibit Hall 3
Diana Li, BA
Sunday, Oct 21
1:15 pm
SU_3_2024 - Nationwide Management and Survival Outcomes of Adenocarcinoma of the Anal Canal
Location: Innovation Hub, Exhibit Hall 3
Richard Li, MD
Sunday, Oct 21
1:15 pm
SU_3_2025 - Safety and Efficacy of Bevacizumab plus Concurrent Chemoradiotherapy for Recurrent or Metastatic Colorectal Cancer
Location: Innovation Hub, Exhibit Hall 3
Yongheng Li, MD, RT, BS
Sunday, Oct 21
1:15 pm
SU_3_2026 - 53BP1 Deletion Induced Treatment Resistance in Neoadjuvant Chemoradiotherapy Rectal Patients By Inhibiting Immune Function
Location: Innovation Hub, Exhibit Hall 3
Hong Ma
Sunday, Oct 21
1:15 pm
SU_3_2027 - Effect of Radiation Therapy Duration on Overall Survival in Anal Squamous Cell Carcinoma: A National Analysis
Location: Innovation Hub, Exhibit Hall 3
Shahil Mehta, BS
Sunday, Oct 21
1:15 pm
SU_3_2028 - The Immune Milieu of Anal Squamous Cell Carcinoma: IDO Expression is Correlated With Poor Outcome
Location: Innovation Hub, Exhibit Hall 3
Devarati Mitra, MD, PhD
Sunday, Oct 21
1:15 pm
SU_3_2029 - Organ Motion During Neoadjuvant Chemoradiotherapy for Rectal Cancer - A Call to Update the RTOG Contouring Guidelines.
Location: Innovation Hub, Exhibit Hall 3
Nataliya Moldovan, MD
Sunday, Oct 21
1:15 pm
SU_3_2030 - Patterns of Care and Outcomes for Early Stage (cT1-T2N0M0) Squamous Cell Carcinoma of the Anus
Location: Innovation Hub, Exhibit Hall 3
Virginia Osborn, MD
Sunday, Oct 21
1:15 pm
SU_4_2032 - Small Cell Carcinoma of the Anus, A Patterns of Care Study Utilizing a Large Hospital-Based Database
Location: Innovation Hub, Exhibit Hall 3
Virginia Osborn, MD
Sunday, Oct 21
1:15 pm
SU_4_2033 - Defining Bowel and Nonsigmoid Bowel Dose Volume Constraints for Pelvic Radiation Therapy in GI Malignancies.
Location: Innovation Hub, Exhibit Hall 3
Sophie Otter, MBBChir
Sunday, Oct 21
1:15 pm
SU_4_2034 - Feasibility Of Wait And Watch Approach After Neoadjuvant Chemoradiotherapy In Rectal Cancer In Low-And Middle- Income Countries : Initial Experience In Tertiary Cancer Centre In India
Location: Innovation Hub, Exhibit Hall 3
Mangesh Patil, MD
Sunday, Oct 21
1:15 pm
SU_4_2035 - HIV-Positive Anal Cancer Patients Treated with Definitive Chemoradiation: Factors Impacting Clinical Outcomes
Location: Innovation Hub, Exhibit Hall 3
Neil Pfister, MD, PhD
Sunday, Oct 21
1:15 pm
SU_4_2037 - An Analysis of Primary Site Radiation, Surgery, and Survival in Metastatic Rectal Cancer: A National Cancer Database Population Study
Location: Innovation Hub, Exhibit Hall 3
Kristofer Roberts, MD – Mayo Clinic
Sunday, Oct 21
1:15 pm
SU_4_2038 - Changes in Pelvic Active Bone Marrow seen on FDG-PET in Patients Receiving Concurrent Chemoradiation for Anal Cancer
Location: Innovation Hub, Exhibit Hall 3
Maxwell Robinson, MS, BS, MSc
Sunday, Oct 21
1:15 pm
SU_4_2039 - Impact of immune status on disease recurrence in HIV+ positive patients diagnosed with anal dysplasia
Location: Innovation Hub, Exhibit Hall 3
Danushka Seneviratne, MD, PhD
Sunday, Oct 21
1:15 pm
SU_4_2040 - Radiation Therapy Dose in Anal Cancer: Patterns of Care and Survival
Location: Innovation Hub, Exhibit Hall 3
Kimberley Mak, MD, MPH
Sunday, Oct 21
1:15 pm
SU_4_2135 - Outcomes following Stereotactic Body Radiation Therapy for Patients with Child-Pugh B or C Hepatocellular Carcinoma
Location: Innovation Hub, Exhibit Hall 3
Aditya Juloori, MD – Cleveland Clinic Foundation
Sunday, Oct 21
1:15 pm
SU_5_2041 - MRI radiomics signature as a potential biomarker to predict different KRAS status in colorectal cancer patients and tumor cells
Location: Innovation Hub, Exhibit Hall 3
Lijun Shen, MD
Sunday, Oct 21
1:15 pm
SU_5_2042 - Time to surgery after neoadjuvant chemoradiation for rectal carcinoma is an independent predictor of total mesorectal excision quality
Location: Innovation Hub, Exhibit Hall 3
Igor Sirak, MD, PhD
Sunday, Oct 21
1:15 pm
SU_5_2043 - Location-Specific Skin Dosimetry Is Associated With Treatment Breaks and Duration In Concurrent Chemoradiotherapy For Anal Cancer
Location: Innovation Hub, Exhibit Hall 3
Matthew Susko, MD, MS
Sunday, Oct 21
1:15 pm
SU_5_2044 - Evaluation of Patient Characteristics, Treatment Decisions and Survival of Young Patients Under The Age of 50 Diagnosed With Colorectal Carcinoma.
Location: Innovation Hub, Exhibit Hall 3
Marcher Thompson, MD
Sunday, Oct 21
1:15 pm
SU_5_2045 - FAK alleviates radiation-induced rectal injury through AKT Signaling Pathway
Location: Innovation Hub, Exhibit Hall 3
Wenzhi Tu, PhD
Sunday, Oct 21
1:15 pm
SU_5_2046 - Outcomes Prediction in Pre-Operative Radiation Therapy Locally Advanced Rectal Cancer: Leucocyte Assessment As Immune Biomarker
Location: Innovation Hub, Exhibit Hall 3
Alexis Vallard, MD
Sunday, Oct 21
1:15 pm
SU_5_2047 - Poor Prognostic and Staging Value of Tumor Deposits in Locally Advanced Rectal Cancer With Neoadjuvant Chemoradiotherapy
Location: Innovation Hub, Exhibit Hall 3
Yaqi Wang, MD
Sunday, Oct 21
1:15 pm
SU_5_2048 - Clinical Study of Bone Marrow-Sparing Neoadjuvant Chemoradiotherapy for Rectal Cancer
Location: Innovation Hub, Exhibit Hall 3
Yijun Wang, MS
Sunday, Oct 21
1:15 pm
SU_5_2049 - Definitive Pelvic Radiation Therapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer
Location: Innovation Hub, Exhibit Hall 3
Yuefeng Wang, MD, PhD
Sunday, Oct 21
1:15 pm
SU_5_2051 - Definitive Radiation Therapy With Chemotherapy for Stage IV Anal Cancer: A National Cancer Database Analysis
Location: Innovation Hub, Exhibit Hall 3
Tyler Wilhite, MD – Mayo Clinic
Sunday, Oct 21
1:15 pm
SU_5_2052 - An analysis of toxicity and outcomes in older versus younger rectal cancer patients treated with trimodality therapy
Location: Innovation Hub, Exhibit Hall 3
Jessica Wong, MD
Sunday, Oct 21
1:15 pm
SU_6_2050 - Intensity-Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy in Rectal Cancer Treated with Neoadjuvant Concurrent Chemoradiation: A Meta-Analysis and Pooled-Analysis of Acute Toxicity
Location: Innovation Hub, Exhibit Hall 3
Chan Woo Wee, MD
Sunday, Oct 21
1:15 pm
SU_6_2053 - Sarcopenia is associated with inferior response to neoadjuvant chemoradiation in patients with locally advanced rectal cancer
Location: Innovation Hub, Exhibit Hall 3
Jeng-You WU, MD
Sunday, Oct 21
1:15 pm
SU_6_2054 - The High Expression of Inhibitory Lymphoid Receptors After Preoperative Radiation Therapy Predicts Favorable Prognosis of Locally Advanced Rectal Cancer
Location: Innovation Hub, Exhibit Hall 3
Junxin Wu, MD
Sunday, Oct 21
1:15 pm
SU_6_2055 - Dosimetric Predictors of Acute Hematologic Toxicity Due to Intensity-Modulated Pelvic Radiation Therapy With Concurrent Chemotherapy for Chinese Rectal and Cervical Cancer Patients
Location: Innovation Hub, Exhibit Hall 3
Yongqiang Yang, MD
Sunday, Oct 21
1:15 pm
SU_6_2056 - Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Locally Advanced Rectal Cancer Patients Treated with Concurrent Weekly Irinotecan in Combination with Capecitabine-Based Chemoradiotherapy and Neoadjuvant IMRT
Location: Innovation Hub, Exhibit Hall 3
Jing Zhang
Sunday, Oct 21
1:15 pm
SU_6_2057 - Assessing Radiation Induced Liver Damage Following MR-Guided Stereotactic Body Radiation Therapy (SBRT): Challenging Current Dose Constraints
Location: Innovation Hub, Exhibit Hall 3
Aleksandra Kuczmarska-Haas, MD
Sunday, Oct 21
1:15 pm
SU_6_2058 - Differing Radiation Doses Associated with Improved Overall Survival in Trimodality Versus Bimodality Treatment for Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Christopher Anker, MD
Sunday, Oct 21
1:15 pm
SU_6_2059 - Acute Toxicities and Short-Term Follow-up of Patients Treated with Pencil-Beam Scanning Proton Beam Radiation Therapy for Esophageal Carcinoma: A Single-Center Experience
Location: Innovation Hub, Exhibit Hall 3
Ronik Bhangoo, MD
Sunday, Oct 21
1:15 pm
SU_6_2060 - Modeling Variability for at Risk Lung Functionality By Location of Esophageal Cancer Radiation Therapy Fields
Location: Innovation Hub, Exhibit Hall 3
Yiqing Butler-Xu, MD
Sunday, Oct 21
1:15 pm
SU_6_2061 - Pilot Study of Potential Activation of c-MYC by Aurora Kinase A in Everolimus-Resistant Localized Esophageal Cancer Treated with XELOX followed by Carboplatin/Radiation
Location: Innovation Hub, Exhibit Hall 3
A. Bapsi Chakravarthy, MD, FASTRO
Sunday, Oct 21
1:15 pm
SU_6_2062 - Concurrent Chemoradiotherapy (CCRT) for Stage I-II Esophageal Cancer Patients
Location: Innovation Hub, Exhibit Hall 3
Junichi Fukada, MD, PhD
Sunday, Oct 21
1:15 pm
SU_7_2063 - Nomogram to predict disease-free survival in stage IB-III thoracic esophageal squamous cell carcinoma patients after radical esophagectomy
Location: Innovation Hub, Exhibit Hall 3
Wei Deng, MD – National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences
Sunday, Oct 21
1:15 pm
SU_7_2064 - Can Mean Pericardial Irradiated Dose (MPD) Predict Pericardial Effusion After Chemoradiotherapy in Esophageal Cancer Patients? ?Normal Tissue Complication Probability (NTCP) Model Based Analyses
Location: Innovation Hub, Exhibit Hall 3
Junichi Fukada, MD, PhD
Sunday, Oct 21
1:15 pm
SU_7_2065 - A Multi-institutional Analysis of Dosimetric Predictors of Toxicity Following Trimodality Therapy for Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Aurelie Garant, MD
Sunday, Oct 21
1:15 pm
SU_7_2066 - A Prospective Pilot Study of Pencil Beam Scanning (PBS) Proton Radiation Therapy (RT) as a Component of Trimodality Therapy for Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Christopher Hallemeier, MD
Sunday, Oct 21
1:15 pm
SU_7_2067 - Effect of Patient Companionship on Patients With Esophageal Cancer Undergoing Definitive Chemoradiotherapy
Location: Innovation Hub, Exhibit Hall 3
Joseph Ho, MD
Sunday, Oct 21
1:15 pm
SU_7_2068 - Radiobiological Determination of
18
F-FDG PET/CT guiding Dose Escalation in Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Man Hu
Sunday, Oct 21
1:15 pm
SU_7_2069 - Propensity Score-Matched Analysis to Evaluate the Impact of Re-irradiation on Long-term Prognosis for Recurrent Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Yunxia Huang, BS
Sunday, Oct 21
1:15 pm
SU_7_2070 - Long-Term Follow-Up Results of Concurrent Chemo-Proton Therapy for Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Hitoshi Ishikawa, MD, PhD
Sunday, Oct 21
1:15 pm
SU_7_2071 - Combination of radiation therapy and anti-PD-1 antibody SHR-1210 in treating patients with esophageal squamous cell cancer
Location: Innovation Hub, Exhibit Hall 3
Zhao Jing
Sunday, Oct 21
1:15 pm
SU_7_2072 - Early Prediction of Response to Radiation Therapy Using Inter-Fractional 18F-FDG PET/CT in Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Nalee Kim, MD
Sunday, Oct 21
1:15 pm
SU_8_2073 - Clinical Characteristics and Prognosis of Thoracicesophageal Squamous Cell Carcinoma with Abdominal Lymph Node Metastasis
Location: Innovation Hub, Exhibit Hall 3
Jiancheng Li, MD
Sunday, Oct 21
1:15 pm
SU_8_2074 - Adherence and Reasons for Non-Adherence to a Tri-Modality Regimen in the Treatment of Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Daniel Koffler
Sunday, Oct 21
1:15 pm
SU_8_2075 - Exploration of Radiosensitivity-related LncRNAs in Esophageal Cancer Stem Cell
Location: Innovation Hub, Exhibit Hall 3
Jiancheng Li, MD
Sunday, Oct 21
1:15 pm
SU_8_2076 - Patient-Reported Outcome Measures during Chemoradiotherapy for Esophageal Cancer and Relationship with Pathologic Response
Location: Innovation Hub, Exhibit Hall 3
Puyao Li, MD
Sunday, Oct 21
1:15 pm
SU_8_2077 - Efficacy and Safety of Apatinib With or Without Radiation Therapy as Second-Line or Beyond Therapy in Patients with Advanced/Recurrent Esophageal Squamous Cell Carcinoma
Location: Innovation Hub, Exhibit Hall 3
Tao Li, MD, PhD
Sunday, Oct 21
1:15 pm
SU_8_2078 - Impact of Chemoradiotherapy Intensity on Pathological Complete Response In Patients With Esophageal Cancer Receiving Trimodality Therapy
Location: Innovation Hub, Exhibit Hall 3
Jhenbin Lin, MD
Sunday, Oct 21
1:15 pm
SU_8_2079 - PD-L1 Expression and the Effect With Radiosensitivity and Prognosis in Esophageal Squamous Cell Carcinom
Location: Innovation Hub, Exhibit Hall 3
Dai Yuan Ma, MD
Sunday, Oct 21
1:15 pm
SU_8_2080 - Lung V20 As a Prognostic Factor of Survival In Patients With Esophageal Cancer Who Received Neoadjuvant Chemoradiotherapy
Location: Innovation Hub, Exhibit Hall 3
Jhenbin Lin, MD
Sunday, Oct 21
1:15 pm
SU_8_2081 - A Reliable Nomogram is identified to predict the overall survival for patients with esophageal squamous cancer after chemoradiation therapy followed by surgery
Location: Innovation Hub, Exhibit Hall 3
Mingwei Ma, MD
Sunday, Oct 21
1:15 pm
SU_8_2082 - Pathologic Tumor Response to Neoadjuvant Chemoradiation Predicts Survival in Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Alexander Moeller, BS
Sunday, Oct 21
1:15 pm
SU_9_2083 - Brachytherapy in the Management of Esophageal Cancer: A Single Institution Experience
Location: Innovation Hub, Exhibit Hall 3
Nikitha Moideen, MD
Sunday, Oct 21
1:15 pm
SU_9_2084 - Possibility of conversion surgery and histological evaluation in definite cT4 patients of esophageal cancer treated with preoperative chemoradiation followed by surgery
Location: Innovation Hub, Exhibit Hall 3
Miyako Myojin, MD, PhD
Sunday, Oct 21
1:15 pm
SU_9_2085 - The Value of Postoperative Radiation Therapy for 1 to 2 Pathological Lymph Nodes Metastases of Esophageal Squamous Cell Carcinoma Using Propensity Score-Matched: Analysis from Two-Center Study
Location: Innovation Hub, Exhibit Hall 3
Wenjie Ni, MD
Sunday, Oct 21
1:15 pm
SU_9_2086 - Dose Dependent Association of Vertebral Body irradiation and Lymphopenia During Chemoradiation for Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Neil Newman, MD, MS
Sunday, Oct 21
1:15 pm
SU_9_2087 - Effect of Adjuvant Radiation Therapy on Survival in Resected Thoracic Esophageal Squamous Cell Carcinoma According to the 8
th
AJCC Stage System: Pooled Analysis of Two Cancer Center in China
Location: Innovation Hub, Exhibit Hall 3
Wenjie Ni, MD
Sunday, Oct 21
1:15 pm
SU_9_2088 - Salvage Radiation Therapy with Elective Nodal Irradiation for Superficial Esophageal Cancer after Incomplete Endoscopic Resection
Location: Innovation Hub, Exhibit Hall 3
Ikuno Nishibuchi, MD, PhD
Sunday, Oct 21
1:15 pm
SU_9_2089 - Safety and Effect of Radiation Therapy Combined with Anti-PD-1 Antibody SHR-1210 As First-Line Treatment on Patients with Intolerable Concurrent Chemoradiotherapy Esophageal Cancer: A Phase 1B Clinical Trial
Location: Innovation Hub, Exhibit Hall 3
Qingsong Pang, MD
Sunday, Oct 21
1:15 pm
SU_9_2090 - Hematologic Toxicity of Single Posterior Pencil-Beam Scanning Approach for Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Amber Post, MD, PhD
Sunday, Oct 21
1:15 pm
SU_9_2092 - Early Response to Chemoradiotherapy By Interim 18F-FDG PET/CT Is Associated With Better Survival in Locally Advanced Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Laurent Quero, MD, PhD, MS
Sunday, Oct 21
1:15 pm
SU_10_2094 - A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
David Routman, MD
Sunday, Oct 21
1:15 pm
SU_10_2095 - Texture Analysis of FDG-PET/CT for Patients with Esophageal SCC Treated By Chemoradiotherapy
Location: Innovation Hub, Exhibit Hall 3
Noriyoshi Takahashi, MD, PhD
Sunday, Oct 21
1:15 pm
SU_10_2096 - Analysis of the Cardiovascular Complications After Definitive Chemoradiotherapy for Esophageal Cancer Using Biological Dose Volume Histogram
Location: Innovation Hub, Exhibit Hall 3
Yuki Takeuchi, MD
Sunday, Oct 21
1:15 pm
SU_10_2097 - Incidence of regional recurrence outside of radiation fields in patients with or without elective nodal irradiation for stage I middle thoracic esophageal cancer
Location: Innovation Hub, Exhibit Hall 3
Shintaro Tsuruoka, MD
Sunday, Oct 21
1:15 pm
SU_10_2099 - Adjuvant Chemotherapy Can Not Prolong the Survival in Patients with Advanced Esophageal Squamous Cell Carcinoma after Chemoradiation -Data from NCT01551589
Location: Innovation Hub, Exhibit Hall 3
Qifeng Wang, MD
Sunday, Oct 21
1:15 pm
SU_10_2100 - Changes in Cardiac Volume during Concurrent Chemoradiotherapy for Esophageal Cancer Based on Repeated Enhanced 4DCT
Location: Innovation Hub, Exhibit Hall 3
Xue Wang
Sunday, Oct 21
1:15 pm
SU_10_2101 - A Chinese Multi-Institutional Analysis of Three Dimensional Conformal Radiation or Intensity-Modulated Radiation Therapy for Non-Operated Localized Esophageal Squamous Cell Carcinoma in Definitive (Chemo)Radiation
Location: Innovation Hub, Exhibit Hall 3
Xin Wang, MD
Sunday, Oct 21
1:15 pm
SU_10_2102 - Predictors of Cardiac Toxicity in Operable Esophageal Cancer Patients Treated With or Without Chemoradiation.
Location: Innovation Hub, Exhibit Hall 3
Jacob Witt, MD
Sunday, Oct 21
1:15 pm
SU_11_2104 - Management of Clinical Stage T1N0M0 Esophageal Cancer
Location: Innovation Hub, Exhibit Hall 3
Andrew Yang, MD, MS – Yonsei Cancer Center
Sunday, Oct 21
1:15 pm
SU_11_2106 - Prognostic Impact of Systemic Inflammatory Markers in Esophageal Squamous Cell Carcinoma treated with Chemoradiation
Location: Innovation Hub, Exhibit Hall 3
Connie Yip, MB, ChB, FRCR
Sunday, Oct 21
1:15 pm
SU_11_2108 - Late Toxicities Differed Maximum Tolerated Dose Determined by Acute Toxicities: Reanalysis of a Phase I/II Trial of Dose Escalation in Unresectable Thoracic Esophageal Cancer by Simultaneous Integrated Boost
Location: Innovation Hub, Exhibit Hall 3
Wen Yu, MD, PhD – Fudan University Shanghai Cancer Center
Sunday, Oct 21
1:15 pm
SU_11_2109 - A Modified N Stage Method Considering Negative Lymph Node and Positive Lymph Node for Esophagus Cancer Evaluation
Location: Innovation Hub, Exhibit Hall 3
Jinling Zhang, MD
Sunday, Oct 21
1:15 pm
SU_11_2110 - Lack of validation of lymphopenia as a prognostic factor in esophageal cancer chemoradiation
Location: Innovation Hub, Exhibit Hall 3
Minsi Zhang, MD
Sunday, Oct 21
1:15 pm
SU_11_2111 - Failure Patterns after Radical Surgery of Thoracic Esophageal Squamous Carcinoma
Location: Innovation Hub, Exhibit Hall 3
Xiaofei Zhang, MD
Sunday, Oct 21
1:15 pm
SU_11_2113 - A Clinical Analysis of Systemic Chemotherapy Combined with Radiation Therapy for Advanced Gastric Cancer
Location: Innovation Hub, Exhibit Hall 3
Hong Dong
Sunday, Oct 21
1:15 pm
SU_11_2115 - A Prospective Phase I Study of Hypo-Fractionated Neoadjuvant Radiation Therapy for Locally Advanced Gastric Cancer
Location: Innovation Hub, Exhibit Hall 3
Ning Li, MD
Sunday, Oct 21
1:15 pm
SU_11_2116 - Using
18
F-FDG PET/CT to Estimate the Length of Gross Tumor and Involvement of Lymph Nodes in Esophagogastric Junction Carcinoma
Location: Innovation Hub, Exhibit Hall 3
Chi-Luan Ma, MB
Sunday, Oct 21
1:15 pm
SU_12_2117 - Survival outcomes and prognostic factors for gastric cancer in the adjuvant setting: An analysis of the National Cancer Database.
Location: Innovation Hub, Exhibit Hall 3
Susanna Nguy, MD
Sunday, Oct 21
1:15 pm
SU_12_2118 - Stage-matched survival differences by ethnicity among Asian gastric cancer patients treated in the United States
Location: Innovation Hub, Exhibit Hall 3
Ryan Rhome, MD, PhD
Sunday, Oct 21
1:15 pm
SU_12_2119 - Patterns of Failure in Gastric Carcinoma After Radical Gastrectomy and the Implication of Target Definition in Post-Operative Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Shubei Wang
Sunday, Oct 21
1:15 pm
SU_12_2120 - Skeletal Muscle Depletion during Chemoradiotherapy and Radiomics Features As Prognostic Factors of Toxicity and Outcomes in Patients with Gastric Cancer
Location: Innovation Hub, Exhibit Hall 3
Wang Yang, MD
Sunday, Oct 21
1:15 pm
SU_12_2121 - Can Chemoradiotherapy Improve Survival After An R1 Resection for Gastric Cancer: A Retrospective Study of A Chinese Cohort
Location: Innovation Hub, Exhibit Hall 3
Meng-long Zhou, MD, PhD
Sunday, Oct 21
1:15 pm
SU_12_2122 - High-Dose Radiation in Liver-Directed Concurrent Chemoradiotherapy Is Effective for Locally Advanced BCLC Stage C Hepatocellular Carcinoma
Location: Innovation Hub, Exhibit Hall 3
Hwa Kyung Byun, MD
Sunday, Oct 21
1:15 pm
SU_12_2123 - Evaluating Safety and Dosimetry of SBRT following
90
Y for Hepatocellular Carcinoma
Location: Innovation Hub, Exhibit Hall 3
Shauna Campbell, DO, RT
Sunday, Oct 21
1:15 pm
SU_12_2124 - Hafnium Oxide Nanoparticles Activated By Radiation Therapy: An Innovative Approach for the Treatment of Liver Cancers
Location: Innovation Hub, Exhibit Hall 3
Enrique Chajon Rodriguez, MD, PhD
Sunday, Oct 21
1:15 pm
SU_12_2125 - Assessment of Online Adaptive MR-Guided SBRT of Liver Cancers
Location: Innovation Hub, Exhibit Hall 3
Nesrin Dogan, PhD
Sunday, Oct 21
1:15 pm
SU_12_2126 - Patterns of Failure and Need for Biliary Intervention Among Patients with Biliary Tract Cancers Treated With Definitive Surgery and Adjuvant Chemoradiation
Location: Innovation Hub, Exhibit Hall 3
Morgan Freret, MD, PhD
Sunday, Oct 21
1:15 pm
SU_13_2031 - Are All Colorectal Oligometastases Equal?
Location: Innovation Hub, Exhibit Hall 3
Sean O'Cathail, MD
Sunday, Oct 21
1:15 pm
SU_13_2127 - Outcomes After Stereotactic Body Radiation Therapy (SBRT) as a Bridging Modality to Liver Transplantation for Hepatocellular Carcinoma (HCC)
Location: Innovation Hub, Exhibit Hall 3
Rashi Garg, MD
Sunday, Oct 21
1:15 pm
SU_13_2128 - Evaluation of Post- Stereotactic Body Radiation Therapy Response Assessment for Hepatocellular Carcinoma: An Appraisal of RECIST, m-RECIST and WHO Criteria.
Location: Innovation Hub, Exhibit Hall 3
Devon Godfrey, PhD
Sunday, Oct 21
1:15 pm
SU_13_2129 - Safety of liver stereotactic body radiation therapy for hepatocellular carcinoma following transarterial radioembolization vs. transarterial chemoembolization
Location: Innovation Hub, Exhibit Hall 3
Camille Hardy, BS
Sunday, Oct 21
1:15 pm
SU_13_2130 - Effect of Treatment Schedule on Fatigue in Hepatocellular Carcinoma Patients Treated With Stereotactic Body Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Shaakir Hasan, DO
Sunday, Oct 21
1:15 pm
SU_13_2131 - Proton Therapy and the Role of Dosimetric Parameters as Predictors for Normal Tissue Complications after Liver-Directed Stereotactic Body Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Katharina Hoebel, MD
Sunday, Oct 21
1:15 pm
SU_13_2132 - Liver stereotactic body radiation therapy modulates systemic pharmacokinetics of sorafenib through p-glycoprotein
Location: Innovation Hub, Exhibit Hall 3
Chen-Hsi Hsieh, MD, PhD
Sunday, Oct 21
1:15 pm
SU_13_2133 - Proton beam therapy for unresectable cholangiocarcinoma
Location: Innovation Hub, Exhibit Hall 3
Sheng-Ping Hung, MD
Sunday, Oct 21
1:15 pm
SU_13_2134 - Predicting survival after liver SBRT by deep learning-based analysis of treatment dose plans
Location: Innovation Hub, Exhibit Hall 3
Bulat Ibragimov, PhD
Sunday, Oct 21
1:15 pm
SU_13_2136 - Comparison of Stereotactic Body Radiation Therapy Combined with or without Transcatheter Arterial Chemoembolization for Patients with Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies
Location: Innovation Hub, Exhibit Hall 3
Tomoki Kimura, MD, PhD
Sunday, Oct 21
1:15 pm
SU_14_2137 - Stereotactic Body Radiation Therapy for Centrally Located Hepatocellular Carcinoma: Outcomes and Toxicities
Location: Innovation Hub, Exhibit Hall 3
Stanislav Lazarev, MD – Mount Sinai Health System
Sunday, Oct 21
1:15 pm
SU_14_2138 - Skeletal Muscle Depletion Predicts the Prognosis of Patients with Hepatocellular Carcinoma Treated with Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Joon-gyo Lee
Sunday, Oct 21
1:15 pm
SU_14_2139 - Higher Risk Liver Stereotactic Body Radiation Therapy (SBRT): Treatment of Child-Pugh Class B and C Patients
Location: Innovation Hub, Exhibit Hall 3
Rebecca Levin-Epstein, MD, BS
Sunday, Oct 21
1:15 pm
SU_14_2140 - Prognostic Significance of Diffusion-Weighted Magnetic Resonance Imaging in Hepatocellular Carcinoma Patients after Radiation Therapy
Location: Innovation Hub, Exhibit Hall 3
Chenghsiang Lo, MD
Sunday, Oct 21
1:15 pm
SU_14_2141 - Functional Liver Image-Guided Hepatic Therapy (FLIGHT) with Hepatobiliary Iminodiacetic Acid (HIDA) Scans: Functional Parameters May Predict for Decompensation after Stereotactic Body Radiation Therapy (SBRT)
Location: Innovation Hub, Exhibit Hall 3
Ke (Colin) Huang, PhD, MS
Sunday, Oct 21
1:15 pm
SU_14_2142 - Clinical Outcomes Using Magnetic Resonance-Guided Stereotactic Body Radiation Therapy in Patients with Locally Advanced Cholangiocarcinoma
Location: Innovation Hub, Exhibit Hall 3
Elaine Luterstein, BS
Sunday, Oct 21
1:15 pm
SU_14_2143 - Dynamic Contrast Enhanced MRI Reveals Acute Changes in Vascular Permeability/Perfusion Following Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma
Location: Innovation Hub, Exhibit Hall 3
Eric Miller, MD, PhD
Sunday, Oct 21
1:15 pm
SU_14_2144 - Central Hepatobiliary Tree As an Organ at Risk for Stereotactic Body Radiation Therapy (SBRT) of the Liver: Is It High Priority for Hepatocellular Carcinoma (HCC)?
Location: Innovation Hub, Exhibit Hall 3
Ram Narayan, MD
Sunday, Oct 21
1:15 pm
SU_14_2145 - Value of Functional Liver Imaging in Heavily Pre-Treated Hepatocellular Carcinoma Patients
Location: Innovation Hub, Exhibit Hall 3
Stephanie Schaub, MD – University of Washington